Selective serotonin reuptake inhibitors

SSRI

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N06AB 1 out of 7 registries used, show all original rules.	107505
4. Check minimum number of events Min. number of events 3	107505
5. Include endpoints None	107505
6. Filter based on genotype QC (FinnGen only)	107505

Control definitions (FinnGen only)

Control exclude: ANTIDEPRESSANTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	SSRI
CONTROL_EXCLUDE	ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N06AB
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Selective serotonin reuptake inhibitors based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	107505	73554	33951
Unadjusted period prevalence (%)	21.88	25.07	14.97
Median age at first event (years)	41.27	39.24	45.66

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
15643: Matched controls
96984

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

26.2

323.0

1625

426

F32.9

ICD-10 Finland

Depressive episode, unspecified

22.6

323.0

2794

924

R53

ICD-10 Finland

Malaise and fatigue

2.6

323.0

3159

8623

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

10.2

323.0

1825

1238

N05AX08

ATC

risperidone; systemic

6.3

323.0

2081

2320

N06AB03

ATC

fluoxetine; oral

37.8

323.0

4099

901

N06AB04

ATC

citalopram; systemic

51.4

323.0

8467

2175

N05BA04

ATC

oxazepam; oral

8.0

323.0

5611

6324

N06AB08

ATC

fluvoxamine; oral

46.0

323.0

742

105

N06AB06

ATC

sertraline; oral

48.0

323.0

3209

518

N07BB01

ATC

disulfiram; oral

10.0

323.0

982

647

N06AA09

ATC

amitriptyline; systemic

6.7

323.0

1474

1478

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

13.8

323.0

1138

549

F51.0

ICD-10 Finland

Nonorganic insomnia

4.9

323.0

1443

1981

N06AA12

ATC

doxepin; systemic

16.9

323.0

1236

490

N06AX26

ATC

vortioxetine; oral

50.1

323.0

942

124

P76

ICPC

Depressive disorder

26.8

323.0

1003

247

N06AX21

ATC

duloxetine; oral

16.3

323.0

1482

620

F34.1

ICD-10 Finland

Dysthymia

39.7

323.0

635

103

N05CF01

ATC

zopiclone; oral

4.2

323.0

6461

13831

N03AG01

ATC

valproic acid; systemic, rectal

6.0

323.0

1135

1249

N05CF02

ATC

zolpidem; oral

4.3

323.0

2281

3670

N05CD07

ATC

temazepam; oral

5.1

323.0

3289

4825

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

132.6

323.0

754

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.0

323.0

1595

2165

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

77.2

323.0

576

SPAT1240

SPAT

Therapeutic discussion

5.9

323.0

1481

1685

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

74.7

323.0

823

N05BA01

ATC

diazepam; systemic, rectal

5.4

323.0

2851

3856

N05AH04

ATC

quetiapine; oral

10.5

323.0

3876

2952

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.2

323.0

1450

1577

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

15.9

323.0

714

291

F32.1

ICD-10 Finland

Moderate depressive episode

19.4

323.0

771

258

P03

ICPC

Feeling depressed

10.7

323.0

1416

891

N06AG02

ATC

moclobemide; oral

30.4

323.0

1143

251

C07AA05

ATC

propranolol; systemic

3.7

323.0

2482

4754

N05BA12

ATC

alprazolam; oral

11.3

323.0

2260

1425

N05AA02

ATC

levomepromazine; systemic

9.8

323.0

1089

732

N06AX16

ATC

venlafaxine; oral

56.0

323.0

2761

369

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

42.7

323.0

1404

223

N05BA06

ATC

lorazepam; systemic, sublingual

7.0

323.0

1236

1172

N06AX12

ATC

bupropion; oral

53.3

323.0

977

121

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.9

323.0

1510

1732

P01

ICPC

Feeling anxious/nervous/tense

6.9

323.0

1313

1268

N03AE01

ATC

clonazepam; systemic

6.3

323.0

1033

1073

N05AH03

ATC

olanzapine; systemic

12.3

323.0

1335

727

N06AB05

ATC

paroxetine; oral

43.2

323.0

1486

235

F41.1

ICD-10 Finland

Generalized anxiety disorder

18.6

323.0

624

216

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

12.2

323.0

1319

727

F32

ICD-10 Finland

Depressive episode

29.0

323.0

869

196

N05BE01

ATC

buspirone; oral

26.7

323.0

720

175

N06AB10

ATC

escitalopram; oral

47.2

323.0

6127

1304

N06AX11

ATC

mirtazapine; oral

13.0

323.0

6746

5346

N06AX03

ATC

mianserin; oral

23.7

323.0

1201

339

N05AB03

ATC

perphenazine; systemic, rectal

11.6

322.5

698

388

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

46.2

315.3

456

N03AX09

ATC

lamotrigine; oral

13.5

314.3

637

304

T36

ICD-10 Finland

Poisoning by systemic antibiotics

10.7

309.5

697

421

N05BA02

ATC

chlordiazepoxide; systemic

11.0

309.5

686

401

N05AX12

ATC

aripiprazole; systemic

13.9

302.6

605

279

N05AF03

ATC

chlorprothixene; systemic

16.6

282.1

528

204

N06AA06

ATC

trimipramine; systemic

24.8

282.0

466

120

N03AX16

ATC

pregabalin; oral

2.4

279.3

2955

8522

N06AX05

ATC

trazodone; oral

38.7

269.3

402

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

32.6

268.3

415

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

14.5

246.3

484

213

P74

ICPC

Anxiety disorder/anxiety state

14.6

245.2

480

209

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

9.2

244.2

595

417

N06AA04

ATC

clomipramine; systemic

51.3

239.2

340

F29

ICD-10 Finland

Unspecified nonorganic psychosis

8.1

237.8

620

489

A02BC02

ATC

pantoprazole; systemic

1.8

237.6

8491

38928

P29

ICPC

Psychological sympt/compl other

6.3

236.0

730

746

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

17.2

235.7

435

161

F40.1

ICD-10 Finland

Social phobias

18.7

235.7

423

144

F10.20

ICD-10 Finland

Alcohol dependence currently independent

13.0

231.5

476

234

G47.3

ICD-10 Finland

Sleep apnoea

2.1

226.6

3254

10712

N05AN01

ATC

lithium; oral

15.1

221.7

429

181

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

221.2

2970

9478

A06AD11

ATC

lactulose; oral

2.2

219.9

2735

8426

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

215.2

1778

4408

N06AX22

ATC

agomelatine; oral

142.9

214.1

272

SPAT1307

SPAT

Psychosocial counselling and guidance

5.1

212.5

774

970

N02BE01

ATC

paracetamol; systemic, rectal

1.8

204.6

11515

59270

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

74.8

202.3

273

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

55.4

200.1

281

N05AL01

ATC

sulpiride; systemic

21.6

195.5

335

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

49.0

190.1

272

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

12.3

189.9

399

206

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

185.3

4261

16562

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

61.5

183.6

254

F41.09

ICD-10 Finland

UNS Panic Syndrome

15.3

181.1

348

144

A02BC05

ATC

esomeprazole; systemic

1.8

181.0

4748

19230

A02BC01

ATC

omeprazole; systemic

1.8

180.7

3934

14987

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

32.3

179.1

277

N05AF01

ATC

flupentixol; systemic

18.7

178.0

319

108

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

20.3

176.4

308

F32.0

ICD-10 Finland

Mild depressive episode

12.6

173.0

359

180

P15

ICPC

Chronic alcohol abuse

6.8

170.5

497

465

P06

ICPC

Sleep disturbance

3.0

170.2

1145

2470

V03AA01

ATC

8.4

170.0

432

325

A02BC03

ATC

lansoprazole; oral

1.8

169.6

3833

14727

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

10.2

169.0

388

242

M03BX02

ATC

tizanidine; oral

1.6

166.9

6284

28102

N03AX12

ATC

gabapentin; oral

2.3

164.2

1753

4956

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

11.0

163.4

361

208

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.5

161.1

1468

3815

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

11.0

158.3

350

202

G04CA02

ATC

tamsulosin; oral

1.6

157.6

6436

29264

N06AX18

ATC

reboxetine; oral

73.6

156.2

211

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

154.5

156.0

197

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.5

152.7

1428

3759

F10.25

ICD-10 Finland

Alcohol dependence continuous use

8.9

151.0

372

265

A02BA02

ATC

ranitidine; systemic

1.9

148.7

2851

10281

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

61.0

147.4

204

P99

ICPC

Psychological disorders other

9.9

146.9

342

219

N02AX02

ATC

tramadol; systemic, rectal

1.6

146.8

5675

25287

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.3

145.8

1627

4684

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

144.1

3683

14584

N05AB01

ATC

dixyrazine; systemic

10.4

142.9

324

197

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

139.0

3951

16121

J01DA01

ATC

[U] cefalexin; systemic

1.5

138.5

8193

40326

A04

ICPC

Weakness/tiredness general

2.2

135.6

1720

5246

F61.0

ICD-10 Finland

Mixed personality disorders

26.4

135.3

219

IGY02

NOMESCO Finland

Psychiatric monitoring contact

10.0

134.1

309

194

N05AD01

ATC

haloperidol; systemic

3.8

134.0

666

1133

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

16.2

132.3

248

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

132.2

4486

19178

IGY99

NOMESCO Finland

Other psychiatric treatment contact

12.9

131.3

269

131

AA1AD

NOMESCO Finland

CT of head and brain

1.7

129.8

3542

14229

R42

ICD-10 Finland

Dizziness and giddiness

1.8

129.3

2774

10336

N06DX01

ATC

memantine; oral

2.5

128.9

1194

3114

F10.24

ICD-10 Finland

Alcohol depence active use

11.5

128.0

276

151

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

2.8

128.0

965

2230

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

127.7

4806

21062

N03AF01

ATC

carbamazepine; oral, rectal

3.1

127.3

827

1730

F31.8

ICD-10 Finland

Other bipolar affective disorders

19.5

127.1

224

N06AX17

ATC

milnacipran; oral

194.1

125.4

156

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

122.8

3851

16047

J01DB01

ATC

cefalexin; oral

1.5

122.2

10744

57053

F99

ICD-10 Finland

Mental disorder, not otherwise specified

11.0

122.2

269

154

N04AA02

ATC

biperiden; systemic

7.4

122.1

336

288

J01CA04

ATC

amoxicillin; systemic

1.5

120.8

10503

55538

F32.8

ICD-10 Finland

Other depressive episodes

18.0

120.6

218

F33

ICD-10 Finland

Recurrent depressive disorder

64.2

119.4

164

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

12.5

119.3

248

125

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

15.9

119.1

225

SPAT1243

SPAT

Psychiatric/psychological examination

6.6

118.5

352

338

A03CA02

ATC

clidinium and psycholeptics; oral

2.9

118.1

850

1905

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

8.8

117.3

289

206

J01AA02

ATC

doxycycline; systemic

1.5

116.6

9640

50181

N05AD03

ATC

melperone; systemic

6.0

115.7

370

393

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.6

115.4

1000

2508

N05AH02

ATC

clozapine; systemic

9.8

113.5

265

171

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

112.6

2638

10057

R03AC02

ATC

salbutamol; inhalant

1.5

111.0

5953

28117

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

7.2

110.6

308

269

L28

ICPC

Limited function/disability (L)

1.8

109.3

2127

7624

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

15.4

108.9

208

F41.8

ICD-10 Finland

Other specified anxiety disorders

10.2

108.4

247

152

R51.80

ICD-10 Finland

Headache

2.2

107.0

1301

3871

M54.5

ICD-10 Finland

Low back pain

1.6

106.7

3185

13010

V03AB30

ATC

12.0

105.5

223

117

R06.0

ICD-10 Finland

Dyspnoea

1.6

104.8

3260

13457

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

9.6

104.0

245

161

M01AE02

ATC

naproxen; oral, rectal

1.5

103.3

6398

31004

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

48.4

102.8

147

AA400

NOMESCO Finland

Electroconvulsive therapy

67.3

102.7

140

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

10.2

102.0

233

144

N05AC02

ATC

thioridazine; oral

6.2

101.2

313

318

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

15.4

100.8

192

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

25.7

100.8

164

N06AA22

ATC

49.7

100.5

143

C07AB07

ATC

bisoprolol; oral

1.5

100.0

7074

35133

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

99.9

1011

2752

J01MA02

ATC

ciprofloxacin; systemic

1.5

99.6

5522

26081

P20

ICPC

Memory disturbance

1.8

99.5

1921

6848

A28

ICPC

Limited function/disability NOS

1.8

99.4

2275

8576

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.5

99.1

338

390

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

97.8

11105

60461

WX110

NOMESCO Finland

Local anesthesy

1.4

97.6

8214

42130

R01AD09

ATC

mometasone; nasal

1.5

97.5

4261

19077

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

10.3

97.1

220

134

K02.1

ICD-10 Finland

Caries of dentine

1.5

96.9

6343

30949

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

96.6

7782

39540

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

96.4

5069

23627

N05CD02

ATC

nitrazepam; oral

5.0

96.1

357

455

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.7

96.0

374

502

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

16.1

96.0

180

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.0

95.0

1467

4815

F39

ICD-10 Finland

Unspecified mood [affective] disorder

10.1

94.5

216

134

F41.00

ICD-10 Finland

Moderate panic disorder

21.4

94.2

161

F03

ICD-10 Finland

Unspecified dementia

2.5

94.1

860

2216

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

12.9

93.4

191

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

92.8

4025

17943

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

92.6

2398

9360

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

42.2

92.3

135

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

91.8

1976

7287

N02AA05

ATC

oxycodone; systemic

1.7

90.6

2136

8103

SPAT1234

SPAT

Support of social functional capacity

2.7

90.4

730

1753

N05BA05

ATC

potassium clorazepate; oral

11.0

90.2

198

113

M01AB05

ATC

diclofenac; systemic, rectal

1.4

90.1

7469

37942

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

7.4

90.1

247

211

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

10.9

89.8

198

114

N06DA03

ATC

rivastigmine; oral, transdermal

2.8

89.6

683

1582

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.1

89.6

405

631

P01AB01

ATC

metronidazole; oral, rectal

1.5

88.9

3627

15914

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

88.9

2035

7648

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

88.5

805

2066

SPAT1254

SPAT

Administration of medicine

1.7

88.5

2141

8180

R06AE07

ATC

cetirizine; oral

1.5

88.5

4163

18860

S06.0

ICD-10 Finland

Concussion

2.0

87.8

1310

4236

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.6

87.7

351

485

E0000UV

ATC

1.5

87.6

4425

20350

A03FA02

ATC

cisapride; oral, rectal

2.2

87.2

1032

3021

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

10.4

87.1

196

118

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

43.4

86.0

125

F20.9

ICD-10 Finland

Schizophrenia, unspecified

6.0

85.9

270

281

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

85.6

946

2683

F31

ICD-10 Finland

Bipolar affective disorder

20.9

85.5

147

F60.9

ICD-10 Finland

Personality disorder, unspecified

19.1

84.9

150

N04BC05

ATC

pramipexole; oral

2.4

84.1

845

2285

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

83.5

5830

28528

P72

ICPC

Schizophrenia

7.3

83.5

230

198

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

83.4

1894

7088

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

83.3

803

2125

P16

ICPC

Acute alcohol abuse

6.3

83.0

252

250

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

6.5

82.9

247

239

KMAK

NOMESCO Finland

1.4

82.4

5224

25075

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

80.7

2637

10922

F60.5

ICD-10 Finland

Anankastic personality disorder

34.6

80.5

122

N06AA10

ATC

nortriptyline; systemic

9.5

80.1

189

125

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

2.6

79.9

650

1565

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.7

79.8

405

700

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

79.4

2137

8398

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

79.3

5011

23994

H03AA01

ATC

levothyroxine sodium; systemic

1.8

79.1

1648

5993

EBA00

NOMESCO Finland

Extraction of tooth

1.5

78.5

4095

18864

G30.1

ICD-10 Finland

Alzheimer disease with late onset

2.2

78.4

959

2847

M02AA07

ATC

piroxicam; topical

1.5

78.3

4007

18381

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

8.7

78.1

193

139

N06BA04

ATC

methylphenidate; oral

4.9

77.1

287

367

F41.3

ICD-10 Finland

Other mixed anxiety disorders

17.5

77.1

140

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

15.7

75.8

143

G44.2

ICD-10 Finland

Tension-type headache

2.2

75.3

919

2723

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.9

74.6

213

194

R01AD08

ATC

fluticasone; nasal

1.6

74.5

2640

11130

N05CD08

ATC

midazolam; nasal, systemic

3.8

74.4

361

600

K59.0

ICD-10 Finland

Constipation

2.3

74.1

797

2227

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.5

73.9

679

1750

J01FA06

ATC

roxithromycin; oral

1.4

73.4

4295

20189

N06AC02

ATC

22.4

72.5

122

SPAT1216

SPAT

Assessment of functional ability

1.6

72.0

2053

8177

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

72.0

5757

28635

R06.5

ICD-10 Finland

Mouth breathing

2.0

71.7

1105

3606

J02AC01

ATC

fluconazole; systemic

1.6

71.5

2120

8533

G04CA01

ATC

alfuzosin; oral

1.5

71.2

2836

12277

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

29.1

71.2

112

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

70.7

3531

16052

F90.0

ICD-10 Finland

Disturbance of activity and attention

4.0

70.7

327

521

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

70.6

1379

4899

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

69.9

1756

6747

M79.6

ICD-10 Finland

Pain in limb

1.5

69.7

3514

15998

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

69.1

8333

44265

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

19.7

68.7

120

C03CA01

ATC

furosemide; systemic

1.4

68.4

4851

23561

G04BD07

ATC

tolterodine; oral

2.5

68.1

615

1569

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

68.0

3926

18347

N05AA01

ATC

chlorpromazine; systemic, rectal

6.9

67.9

194

177

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

67.8

3105

13845

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

67.7

2739

11881

N06DA02

ATC

donepezil; oral

2.1

67.1

877

2677

A02BA04

ATC

nizatidine; systemic

1.9

66.3

1061

3510

M01AC06

ATC

meloxicam; systemic, rectal

1.5

66.3

3348

15223

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.5

66.0

221

250

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

65.9

3639

16838

IGV01

NOMESCO Finland

Psychiatric network contact

12.3

65.6

136

N05CD05

ATC

triazolam; oral, sublingual

4.5

65.3

266

375

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

65.3

3201

14460

F41

ICD-10 Finland

Other anxiety disorders

12.8

65.2

133

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

65.1

2659

11547

WX290

NOMESCO Finland

Other blockade of nerve

1.4

64.8

4296

20567

F05.9

ICD-10 Finland

Delirium, unspecified

3.2

64.5

379

735

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

64.3

806

2414

SPAT1238

SPAT

Brief therapy

10.0

64.2

147

UKC02

NOMESCO Finland

Cystoscopy

1.5

64.1

3092

13911

SPAT1301

SPAT

No procedures

1.4

63.7

4084

19416

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

63.5

1770

6989

R41.0

ICD-10 Finland

Disorientation, unspecified

2.6

63.5

526

1280

F33.8

ICD-10 Finland

Other recurrent depressive disorders

75.6

63.4

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

11.8

63.4

134

D07AC01

ATC

betamethasone; topical

1.4

63.4

3998

18949

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

63.3

5710

28790

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

63.1

2888

12845

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

62.8

1443

5390

R35

ICD-10 Finland

Polyuria

1.9

62.7

1066

3605

L03

ICPC

Low back symptom/complaint

1.6

62.6

2184

9133

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.8

62.2

236

309

M01AX17

ATC

nimesulide; oral

1.5

62.2

2645

11576

R11

ICD-10 Finland

Nausea and vomiting

2.1

62.0

823

2525

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

62.0

1910

7741

IGP01

NOMESCO Finland

Psychiatric family contact

8.7

61.8

152

109

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

61.3

1526

5835

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

20.0

61.1

106

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

61.1

4534

22089

IHZ05

SPAT

5.1

61.0

220

272

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

60.7

1979

8135

M01AH02

ATC

rofecoxib; oral

1.7

60.6

1431

5386

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

60.2

2988

13498

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

60.2

3830

18148

F22.0

ICD-10 Finland

Delusional disorder

6.2

60.0

184

186

S01.0

ICD-10 Finland

Open wound of scalp

1.8

59.5

1116

3903

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

59.5

2332

10013

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

16.6

59.1

109

W19

ICD-10 Finland

Unspecified fall

1.8

59.0

1206

4338

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

59.0

8099

43386

UJF32

NOMESCO Finland

Coloscopy

1.4

58.9

3189

14646

M48.0

ICD-10 Finland

Spinal stenosis

1.7

58.7

1526

5904

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

62.3

58.3

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

58.3

1411

5345

F43.1

ICD-10 Finland

Post-traumatic stress disorder

7.9

58.2

151

119

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

47.0

58.1

J01EA01

ATC

trimethoprim; systemic

1.6

57.9

1939

8013

Z72.1

ICD-10 Finland

Alcohol use

5.0

57.9

210

262

R03BB04

ATC

tiotropium bromide; inhalant

1.6

57.6

1722

6916

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

9.6

57.6

134

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

57.4

2088

8802

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

6.7

57.4

167

157

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

50.5

57.3

30041

ICD-8 Finland

Neuroses, Depressiva

5.0

57.3

207

257

E000001

ATC

1.5

57.3

2275

9788

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

25.2

57.2

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

10.4

57.1

128

J01FA10

ATC

azithromycin; systemic

1.3

57.0

5620

28592

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

56.6

3684

17488

309

Kela drug reimbursment

Nalmefene and naltrexone

24.1

56.6

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.5

56.6

487

1211

A10BA02

ATC

metformin; oral

1.4

56.5

4081

19731

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

56.2

619

1747

R07.3

ICD-10 Finland

Other chest pain

1.8

55.5

1057

3712

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

55.2

1288

4824

Z71.8

ICD-10 Finland

Other specified counselling

1.5

55.2

2262

9791

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

55.1

488

1231

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

55.1

6841

35961

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

54.8

489

1240

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

54.8

2390

10483

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

54.8

1797

7384

SPAT1229

SPAT

Assessment of need for aid

1.9

54.8

971

3327

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

54.5

5648

28896

C10AA01

ATC

simvastatin; oral

1.3

54.4

6613

34631

F60.8

ICD-10 Finland

Other specific personality disorders

30.8

54.3

G04BD08

ATC

solifenacin; oral

2.0

54.0

818

2646

J01CA08

ATC

pivmecillinam; oral

1.8

53.5

977

3382

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

53.4

1433

5583

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

53.4

801

2580

SPAT1263

SPAT

Sampling

1.3

53.3

5092

25700

R05FB02

ATC

cough suppressants and expectorants

1.4

53.3

4224

20699

188

Kela drug reimbursment

Psychosis requiring demanding treatment

13.1

53.1

107

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

52.5

1001

3514

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

52.0

1524

6079

R55

ICD-10 Finland

Syncope and collapse

1.6

51.8

1552

6227

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

51.5

1651

6737

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

51.4

709

2209

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

17.9

51.3

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.4

51.3

491

1292

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

71.6

51.3

C05AA08

ATC

fluocortolone; rectal, topical

1.6

51.3

1479

5874

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

51.2

5659

29144

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

51.0

5892

30532

SPAT1241

SPAT

Extensive assessment of psychosocial situation

6.5

50.9

150

144

P25

ICPC

Phase of life problem adult

4.1

50.9

225

345

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

8.7

50.9

125

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

11.7

50.7

107

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

50.5

1120

4127

J01FF01

ATC

clindamycin; systemic

1.4

50.4

3015

14048

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

50.2

3670

17713

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

50.1

2012

8651

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

13.9

49.9

SPAT1235

SPAT

Mental health, emotional support

17.5

49.9

SPAT1265

SPAT

Breathalyser

6.4

49.8

148

144

F51

ICD-10 Finland

Nonorganic sleep disorders

4.3

49.6

210

309

F84.5

ICD-10 Finland

Asperger syndrome

7.7

49.5

130

105

P19

ICPC

Drug abuse

6.4

49.2

147

144

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.9

48.9

180

229

R01AD01

ATC

beclometasone; nasal

1.6

48.8

1298

5040

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

48.8

956

3385

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

128.6

48.7

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

29.6

48.7

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

48.5

3918

19195

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

48.2

2592

11828

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

6.6

48.2

140

132

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

48.1

1946

8375

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

48.1

1625

6710

R41.3

ICD-10 Finland

Other amnesia

2.6

48.1

403

987

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

12.3

48.0

R13

ICD-10 Finland

Dysphagia

1.9

47.8

791

2642

G20

ICD-10 Finland

Parkinson disease

2.2

47.7

561

1631

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

47.7

3852

18864

D07AA02

ATC

hydrocortisone; topical

1.6

47.3

1499

6090

P27

ICPC

Fear of mental disorder

7.6

47.3

125

102

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.3

47.2

512

1435

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

47.1

564

1653

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

47.0

763

2530

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

46.4

46.9

D07AC13

ATC

mometasone; topical

1.4

46.9

3129

14838

F01.9

ICD-10 Finland

Vascular dementia, unspecified

3.0

46.9

302

628

G04BD12

ATC

mirabegron; oral

1.7

46.6

1201

4618

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

46.6

4019

19867

A01

ICPC

Pain general/multiple sites

2.0

46.6

695

2232

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

46.5

1135

4300

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

46.3

2006

8758

C07AB02

ATC

metoprolol; systemic

1.4

46.1

3165

15075

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.6

46.1

388

953

F93.89

ICD-10 Finland

Other childhood emotional disorders

7.1

46.1

128

113

N03AF02

ATC

oxcarbazepine; oral

2.6

45.9

387

951

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

5.5

45.9

154

176

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

45.8

608

1862

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

3.4

45.6

254

475

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

45.4

4233

21161

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

45.4

515

1473

Z75.5

ICD-10 Finland

Holiday relief care

3.9

45.2

210

338

R25.1

ICD-10 Finland

Tremor, unspecified

2.6

45.0

372

903

WYA20

NOMESCO Finland

Home visit

3.4

44.9

243

445

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

44.8

2017

8869

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

44.5

4450

22464

H02AB06

ATC

prednisolone; systemic

1.3

44.4

5600

29199

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

12.7

44.3

M01AG02

ATC

tolfenamic acid; oral, rectal

1.9

44.3

681

2214

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.9

44.2

163

208

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

44.2

1286

5109

D07XC01

ATC

betamethasone, combinations; topical

1.6

44.2

1506

6224

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

27.2

44.1

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

11.6

44.0

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

43.7

2252

10172

S72.0

ICD-10 Finland

Fracture of neck of femur

2.1

43.7

569

1731

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

43.5

2352

10720

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

43.5

1682

7156

IHZ02

SPAT

7.4

43.3

117

SPAT1053

SPAT

Memory test

1.4

43.2

2285

10368

N05AF05

ATC

zuclopenthixol; systemic

6.0

43.2

135

141

J01MA06

ATC

norfloxacin; oral

1.7

43.2

1069

4062

K30

ICD-10 Finland

Functional dyspepsia

1.8

43.1

824

2892

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.0

43.0

657

2128

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

43.0

530

1574

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.3

43.0

245

467

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

42.9

3965

19758

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

42.9

2054

9141

T90

ICPC

Diabetes non-insulin dependent

1.4

42.9

3113

14939

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

2.3

42.8

448

1235

XKD00

NOMESCO Finland

Uroflowmetry

1.3

42.8

3623

17817

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

20.7

42.7

A01AB09

ATC

miconazole; local oral

1.8

42.6

855

3049

IEV99

NOMESCO Finland

Other psychiatric network intervention

12.8

42.4

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

4.6

42.4

167

229

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

42.3

743

2534

C08CA01

ATC

amlodipine; oral

1.3

42.3

4770

24449

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

31.1

42.2

J01MA12

ATC

levofloxacin; systemic

1.4

42.2

2551

11860

P58

ICPC

Psychological, Therapeutic counselling/listening

7.5

42.0

112

C01DA14

ATC

isosorbide mononitrate; oral

1.4

42.0

2976

14217

SPAT1389

SPAT

Visit based on need for special support

3.2

41.5

246

482

N07BA03

ATC

varenicline; oral

2.4

41.4

403

1071

S22.3

ICD-10 Finland

Fracture of rib

1.7

41.4

879

3191

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

23.5

41.3

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

37.9

41.3

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

10677

37887

1.57

322.53

2.4

2.0

—

(3026782) Osmolality of Urine

13164

48996

1.51

320.91

2.8

2.7

mosm/kgh2o

533.0

561.1

32.97

11189

41830

(40761511) CBC panel - Blood by Automated count

60723

298087

1.61

317.65

15.0

11.4

—

(3030467) Casts [#/volume] in Urine by Automated count

18097

70302

1.48

307.65

3.3

3.0

e6/l

0.4

0.06

13615

52448

(3021960) Folate [Moles/volume] in Serum or Plasma

16365

52040

1.86

307.65

1.6

1.5

nmol/l

20.1

20.2

0.25

14215

44769

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2279

3672

3.34

307.65

1.5

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

60893

282842

2.14

307.65

17.7

14.1

mmol/l

4.0

24.06

59232

274584

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

20165

72241

1.66

307.65

2.3

2.0

u/l

230.4

205.8

1.41

18840

67942

(3013115) Eosinophils [#/volume] in Blood

33933

136876

1.60

307.65

6.7

5.9

e9/l

0.2

0.77

29737

120691

(3027008) Opiates [Presence] in Urine

5040

10840

2.56

307.65

2.9

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

14190

50509

1.60

307.65

1.4

g/l

2.4

1.08

8281

31994

(3013826) Glucose [Moles/volume] in Serum or Plasma

36950

152814

1.59

307.65

4.9

4.5

mmol/l

6.7

0.82

34512

141112

(3031040) Bacteria [#/volume] in Urine by Automated count

41488

175983

1.61

307.65

4.9

3.9

e6/l

1605.8

1102.9

0.92

645

2429

(3024561) Albumin [Mass/volume] in Serum or Plasma

28282

106405

1.68

307.65

4.5

4.9

g/l

35.9

35.6

13.81

26109

98973

(3013650) Neutrophils [#/volume] in Blood by Automated count

37204

153030

1.61

307.65

10.1

8.5

e9/l

4.2

4.1

6.39

32447

133755

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7530

20231

2.08

307.65

2.1

2.3

nmol/l

370.8

379.7

2.96

6849

18781

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

23738

93858

1.51

307.65

3.8

3.2

ng/l

46.0

63.3

1.81

15131

61048

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

44243

185168

1.72

307.65

3.8

2.7

u/l

50.3

44.8

24.82

41299

174413

(3048689) Calprotectin [Mass/mass] in Stool

9628

31675

1.70

307.65

2.3

2.6

ug/g

121.9

139.9

4.78

7406

25292

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

55310

260839

1.59

307.65

14.0

11.6

ml/min/173m2

86.0

83.5

116.87

45593

212898

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

27985

102186

1.74

307.65

2.4

2.2

nmol/l

3321.8

76.4

0.50

25257

92667

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

51108

203657

2.24

307.65

4.5

3.6

pmol/l

14.5

14.8

159.14

46711

185489

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1261

661

10.21

307.65

13.1

14.3

nmol/l

845.7

1596.2

0.45

1226

637

(3016879) Cocaine [Presence] in Urine

4865

9689

2.77

307.65

3.0

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

46346

196820

1.73

307.65

4.1

3.8

mm/h

11.3

11.5

2.29

42734

182907

(3044889) 12 lead EKG panel

41950

182529

1.54

307.65

3.8

3.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

679

404

8.92

307.65

2.4

2.6

nmol/l

149.9

156.3

0.40

578

353

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1208

444

14.56

307.65

11.8

14.2

mmol/l

0.6

1.83

1108

414

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1319

704

10.03

307.65

17.7

21.3

nmol/l

2171.2

2364.6

0.06

1269

674

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

61911

301767

1.79

307.65

11.3

9.2

u/l

27.9

26.5

21.37

59789

291425

(3002030) Lymphocytes/100 leukocytes in Blood

31671

129559

1.53

307.65

6.3

6.0

28.3

28.1

1.92

29362

121248

(3000764) Benzodiazepines [Presence] in Urine

5041

10706

2.60

307.65

2.9

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

4375

7478

3.22

307.65

3.0

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12517

41180

1.73

307.65

2.8

3.1

mmol/l

2.4

11.44

10780

35998

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23852

83564

1.77

307.65

3.4

3.1

u/l

33.3

33.8

0.23

22422

79585

(3011288) Drugs identified in Urine by Screen method

4229

5696

4.10

307.65

4.0

2.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

61568

300236

1.74

307.65

17.5

14.1

umol/l

75.7

77.5

34.27

61547

300058

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

13012

28627

2.72

307.65

2.2

1.5

1.4

83.58

11383

25713

(3001604) Monocytes [#/volume] in Blood

32819

131684

1.60

307.65

6.2

5.8

e9/l

0.6

1.04

28318

114498

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

14806

48719

1.76

307.65

1.7

1.6

pmol/l

18597447.6

39617746.7

5.32

12174

40765

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

56655

264095

1.73

307.65

4.9

4.0

mmol/l

6.0

5.9

48.80

51857

243059

(3021589) Normoblasts [#/volume] in Blood

28092

119060

1.41

307.65

9.9

9.0

e9/l

0.0

1.28

22759

98233

(3028300) Cannabinoids [Presence] in Urine

5057

10858

2.57

307.65

3.0

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

9826

34037

1.61

307.65

2.3

2.0

—

(3032080) INR in Blood by Coagulation assay

24377

101576

1.41

307.65

8.3

8.6

inr

1.2

1.3

12.55

7350

29305

(3018010) Neutrophils/100 leukocytes in Blood

31251

127589

1.53

307.65

6.1

5.8

57.1

57.2

0.96

29068

119935

(3019550) Sodium [Moles/volume] in Serum or Plasma

60804

281902

2.15

307.65

17.6

13.9

mmol/l

139.5

139.7

46.72

59246

274261

(40758558) Short blood count panel - Blood

16945

64794

1.50

307.65

7.2

6.7

—

(3019198) Lymphocytes [#/volume] in Blood

33783

136388

1.60

307.65

6.2

5.8

e9/l

2.0

1.9

2.03

29699

120728

(3018418) pH of Serum or Plasma

19671

70195

1.66

307.65

3.8

4.3

7.4

0.99

3733

13230

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1010

684

7.87

307.65

1.9

2.1

—

(3022096) Basophils/100 leukocytes in Blood

29823

120587

1.53

307.65

6.3

6.0

0.7

0.14

27644

112923

(3000850) Epithelial cells [#/volume] in Urine

14045

52743

1.50

307.65

2.7

2.5

e6/l

6.2

5.3

9.69

12255

46015

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

16479

57697

1.66

307.65

1.3

u/ml

1.3

1.9

7.78

4267

16051

(3023368) Bacteria identified in Blood by Culture

17361

66690

1.49

307.65

4.5

4.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

59475

282952

1.78

307.65

15.8

12.3

mg/l

22.4

23.9

19.69

48289

219268

(4198724)

907

650

7.43

307.65

2.6

2.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

33838

131214

1.70

307.65

5.7

6.1

umol/l

10.6

11.7

45.64

31738

124576

(3027944) Amphetamines [Presence] in Urine

4893

10779

2.50

307.65

2.8

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

3389

2356

7.91

307.65

3.3

2.4

—

(36304419) Bacteria [Presence] in Urine

17772

68650

1.49

307.65

3.2

3.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

29586

108876

1.75

307.65

5.7

6.1

mmol/l

1.2

4.00

26732

98725

(3006504) Eosinophils/100 leukocytes in Blood

30718

124477

1.54

307.65

6.2

5.9

2.8

2.9

0.58

28481

116497

(3015377) Calcium [Moles/volume] in Serum or Plasma

23284

78846

1.84

307.65

3.0

3.4

mmol/l

2.4

0.71

20322

69084

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

48627

201073

1.93

307.65

7.5

7.2

u/l

77.1

77.5

1.30

45604

189556

(3009466) Valproate [Moles/volume] in Serum or Plasma

2182

2019

5.84

307.65

5.6

4.4

umol/l

367.2

368.6

0.13

1896

1724

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

22117

78124

1.72

307.65

2.8

2.5

u/l

55.7

59.6

13.21

20172

72553

(3019069) Monocytes/100 leukocytes in Blood

30859

125185

1.54

307.65

6.6

6.2

8.4

8.6

18.43

28758

117717

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

53560

247357

1.63

307.65

6.1

5.1

mmol/mol

39.5

39.3

2.82

49582

230476

(3001122) Ferritin [Mass/volume] in Serum or Plasma

30638

115583

1.71

307.65

3.0

2.8

ug/l

109.8

125.7

16.51

28195

108110

(3026008) Bacteria identified in Urine by Culture

19012

73670

1.49

307.65

3.3

2.8

—

(3018095) Leukocytes [#/volume] in Urine

22868

91753

1.47

307.65

3.8

3.5

e6/l

83.0

96.5

1.49

16152

63936

(3002582) Erythrocytes [#/volume] in Urine

19684

77403

1.47

307.65

3.4

3.1

e6/l

81.6

97.5

0.65

15080

59013

(3037467) Urinalysis macro (dipstick) panel - Urine

42938

186849

1.56

307.65

4.6

3.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

32281

120990

1.76

307.65

6.3

6.7

mmol/l

1.2

1.38

27011

102389

(3015736) pH of Urine

24947

101527

1.46

307.65

3.5

3.1

6.0

5.7

0.60

(40768797) Stomach Pathology biopsy report

9572

32666

1.63

307.65

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

20395

78329

1.53

307.65

3.4

3.2

mmol/l

7.8

8.1

0.56

17037

66557

(3012095) Magnesium [Moles/volume] in Serum or Plasma

10927

38716

1.58

307.65

3.2

3.5

mmol/l

0.8

2.58

10091

36259

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

17702

60863

1.71

307.65

2.3

2.2

mg/l

2.9

1.60

14938

52265

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

57557

249346

2.30

307.65

5.5

4.2

mu/l

2.0

2.1

0.61

53387

229364

(3019309) Folate [Moles/volume] in Red Blood Cells

14248

39554

2.13

307.65

1.8

1.7

nmol/l

1152.8

1151.7

0.05

10806

29940

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

28154

96448

1.91

307.65

2.1

1.9

pmol/l

97.3

95.4

7.39

15025

51130

(3006315) Basophils [#/volume] in Blood

32992

132281

1.60

307.65

6.2

5.8

e9/l

0.0

1.23

28437

115028

(42870588) Differential panel, method unspecified - Blood

22888

88174

1.55

307.65

5.8

6.0

—

(3035350) Ketones [Presence] in Urine by Test strip

30449

132865

1.37

306.83

3.8

3.3

estimate

0.0

2.75

5980

24093

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6965

22430

1.71

306.54

2.7

2.4

u/l

46.6

46.7

0.00

5924

19325

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

14669

56412

1.47

302.18

1.8

mg/l

1.1

1.2

4.26

10858

42903

(3021601) Nitrite [Presence] in Urine by Test strip

30440

133268

1.36

296.60

5.1

4.5

estimate

0.0

0.46

6112

24772

(3033658) Prothrombin time (PT) actual/Normal

16523

65261

1.44

294.90

4.1

3.8

92.1

89.7

26.07

16048

63696

(3009261) Glucose [Presence] in Urine by Test strip

30682

134731

1.36

291.32

3.9

3.3

estimate

0.0

0.01

5921

24051

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

10694

38886

1.53

286.27

1.9

1.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1084

1552

3.72

272.92

1.7

1.3

promille

1.5

1.3

1.87

821

1244

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

655

590

5.89

272.43

2.4

1.6

umol/l

152.0

113.8

1.35

324

283

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6322

20456

1.69

271.49

2.5

2.1

nmol/l

12.6

12.4

0.72

5529

18420

(3003458) Phosphate [Moles/volume] in Serum or Plasma

8869

31345

1.56

267.67

5.1

6.5

mmol/l

1.0

2.14

8179

29360

(3042517) Benzodiazepines panel - Urine

304

24.35

263.21

3.1

1.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

3556

9733

1.97

260.00

1.7

1.6

mu/l

331.1

291.3

4.97

3159

8889

(3022948) Iron [Moles/volume] in Serum or Plasma

10567

39126

1.50

256.79

2.3

2.6

umol/l

13.4

13.8

0.38

9648

36500

(3013512) EKG study

17443

71071

1.39

253.81

3.9

3.7

—

(3019150) Specific gravity of Urine by Refractometry

14389

56981

1.42

245.20

4.1

3.6

kg/l

1.0

0.47

1958

9070

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9767

35942

1.50

243.03

2.3

2.6

g/l

2.4

2.3

20.25

8859

33503

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4879

15190

1.74

238.76

2.9

3.6

pmol/l

4.5

4.6

7.77

4247

13761

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8004

28306

1.55

238.58

2.6

2.8

umol/l

7.7

9.0

5.53

6727

24919

(36660697) Celiac disease serology panel - Serum

6115

20505

1.63

226.88

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6479

22166

1.59

221.29

2.3

g/l

0.2

7.79

5918

20775

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2177

5233

2.23

220.95

2.1

1.8

pmol/l

192.3

197.0

1.10

2048

4987

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

12195

47681

1.42

219.54

3.8

3.5

ng/l

308.9

599.7

10.26

8704

36007

(3017143) Hepatitis C virus Ab [Presence] in Serum

9120

33848

1.48

215.18

1.7

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

8235

29946

1.51

214.33

1.8

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5188

16914

1.66

213.99

1.7

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

11299

43778

1.43

213.02

1.3

iu/ml

34.7

36.9

0.18

3116

14121

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9003

33511

1.48

208.79

2.4

2.7

22.6

23.2

2.60

7661

28776

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2889

7936

1.96

208.05

1.9

1.6

nmol/l

38.8

41.8

8.01

2812

7767

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

7378

26395

1.53

206.56

1.8

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

9326

35086

1.46

204.51

1.4

1.3

titre

477.0

566.4

4.17

1727

7192

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4592

14675

1.69

203.53

3.3

3.6

kpa

5.2

5.1

9.07

4258

13542

(3009343) pH of Capillary blood

4539

14480

1.70

202.44

3.3

3.6

7.4

1.09

620

1837

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

7320

26284

1.52

201.12

1.8

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4401

13966

1.70

199.97

3.2

3.5

mmol/l

1.7

1.6

0.46

3294

10053

(3002385) Erythrocyte distribution width [Ratio]

49419

238679

1.32

199.53

19.4

14.8

13.7

13.6

7.69

48369

233606

(3023183) Ammonium ion [Moles/volume] in Plasma

1839

4343

2.26

194.17

2.7

umol/l

33.8

33.9

0.06

1567

3662

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

56904

281011

1.38

194.15

5.0

4.4

mmol/l

2.8

15.87

52348

261531

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2348

6145

2.05

192.71

1.4

ug/g

286.6

271.5

1.93

1303

3595

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

16174

67503

1.34

191.61

2.9

3.0

ng/l

1129.4

1493.1

22.77

13297

57884

(46235355) HIV 1 and 2 tests - Meaningful Use set

14428

59193

1.36

191.05

2.0

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

16840

70809

1.33

189.27

4.3

3.6

estimate

0.0

4.32

5909

23639

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

10989

43266

1.40

186.26

2.8

2.7

e6/l

1.4

1.1

0.50

6090

24592

(40760892) CBC W Ordered Manual Differential panel - Blood

14631

60369

1.35

185.89

4.7

4.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10509

41111

1.41

184.63

1.3

1.2

u/ml

9.6

12.7

4.18

3894

16467

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

15989

66985

1.33

183.06

1.7

1.6

mmol/l

1.5

1.3

71.98

13438

57005

(1002224) Polysomnography panel

3375

10232

1.77

179.04

1.1

1.0

—

(3012516) Albumin [Mass/volume] in Urine

17130

72878

1.32

174.56

3.3

mg/l

368.4

408.8

0.51

10805

46942

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

23425

103984

1.28

172.90

4.1

3.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

17938

76897

1.31

172.65

4.1

4.0

mg/mmol

8.9

9.8

1.09

11192

49759

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

10308

40630

1.39

171.99

3.0

2.8

e6/l

3.0

2.7

1.32

5413

22103

(3019225) pH of Specimen

6482

23407

1.51

171.60

3.9

4.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

5934

21043

1.53

170.86

6.6

7.2

mmol/l

1.4

1.3

2.04

5682

20302

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

55937

276818

1.34

169.37

4.5

4.0

mmol/l

4.6

4.7

30.51

51742

259247

(3011397) Hemoglobin [Presence] in Urine by Test strip

14611

61020

1.33

168.39

3.8

3.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7933

30064

1.44

164.21

7.2

6.4

—

(3007461) Platelets [#/volume] in Blood

63697

322668

1.52

163.31

24.2

17.6

e9/l

255.5

250.5

65.88

62176

313939

(4010399)

5047

17440

1.56

162.59

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

5971

21467

1.51

160.78

2.2

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

4910

16939

1.57

159.14

2.1

1.8

—

(3035941) MCH [Entitic mass]

63713

322997

1.51

158.14

24.1

17.5

30.3

30.2

9.83

62793

318490

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

55460

274774

1.32

157.81

4.5

4.0

mmol/l

1.4

1.5

189.96

51006

256371

(3026361) Erythrocytes [#/volume] in Blood

63721

323075

1.51

157.49

24.2

17.6

e12/l

4.5

31.94

62025

313462

(3024731) MCV [Entitic volume]

63714

323037

1.51

157.38

24.1

17.5

90.8

90.6

24.54

62793

318514

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

53740

265132

1.30

157.23

4.0

3.6

mmol/l

1.4

1.3

268.84

49082

246352

(3010813) Leukocytes [#/volume] in Blood

63731

323158

1.51

157.01

24.3

17.6

e9/l

6.9

6.7

47.11

62047

313533

(3002032) Base excess in Venous blood by calculation

6135

22322

1.49

155.71

3.9

4.0

mmol/l

2.0

1.8

4.23

5016

18247

(3000963) Hemoglobin [Mass/volume] in Blood

63729

323217

1.50

155.43

24.3

17.7

g/l

135.7

136.4

26.89

62820

318716

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6141

22406

1.49

153.64

3.9

4.0

kpa

5.9

5.8

10.68

5904

21790

(3009214) Lutropin [Units/volume] in Serum or Plasma

2756

8228

1.79

153.29

1.4

u/l

8.5

9.5

3.29

2202

6819

(3012544) pH of Venous blood

6323

23239

1.48

152.52

3.9

4.0

7.4

0.01

114

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

40924

195899

1.25

148.37

3.5

3.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5363

19238

1.51

145.16

3.7

3.9

mmol/l

1.2

0.24

4560

16988

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5086

18058

1.52

144.39

1.2

iu/ml

126.8

152.4

3.58

1769

7000

(3014576) Chloride [Moles/volume] in Serum or Plasma

7916

30679

1.40

143.15

7.1

7.2

mmol/l

104.2

104.6

12.33

7731

30043

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4084

13858

1.59

141.37

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

4304

14790

1.57

141.21

1.3

1.2

—

(3022313) Gas panel - Capillary blood

3244

10418

1.67

139.57

3.4

3.7

—

(3000494) Fungus identified in Specimen by Culture

7637

29536

1.41

139.47

1.5

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2037

5700

1.91

138.26

1.3

mg/l

493.2

548.4

2.26

1930

5451

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1284

3005

2.27

138.14

1.6

—

(3003396) Base excess in Arterial blood by calculation

7160

27428

1.42

137.90

7.2

7.4

mmol/l

1.2

0.9

6.00

5661

21317

(3042936) Bacteria identified in Isolate by Culture

9017

35933

1.37

137.59

2.1

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

5082

18241

1.50

136.77

3.4

3.3

kpa

4.7

4.6

0.77

4855

17674

(3022145) Colonoscopy Study observation

7365

28397

1.41

136.66

1.3

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

19159

84781

1.26

136.36

2.4

2.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3465

11405

1.63

135.54

4.0

4.6

mmol/l

24.3

24.0

3.79

3105

10308

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7139

27431

1.41

134.95

7.2

7.4

kpa

5.1

5.0

14.47

6795

26135

(3027801) Oxygen [Partial pressure] in Arterial blood

7134

27416

1.41

134.72

7.2

7.4

kpa

11.9

12.8

36.71

6794

26117

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

13131

55488

1.30

134.21

1.7

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2869

9035

1.70

132.50

3.5

3.9

mmol/l

24.9

24.7

1.89

2677

8359

(3023323) Follitropin [Units/volume] in Serum or Plasma

3699

12487

1.59

130.50

1.4

1.3

iu/l

23.7

27.2

8.21

3105

10843

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6485

24652

1.42

129.80

3.8

3.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1980

5619

1.88

128.80

1.4

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2577

7960

1.73

127.39

2.2

2.4

ug/l

444.9

595.8

1.59

2400

7451

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1804

5011

1.92

125.00

1.4

1.5

e6/l

1561.4

1711.4

0.08

1488

4047

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1800

5007

1.92

124.20

1.3

1.4

e6/l

19.4

36.7

2.18

1403

3855

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3934

13663

1.55

122.63

1.7

1.6

—

(3000991) Gas panel - Venous blood

5501

20514

1.45

121.62

8.0

8.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4053

14211

1.53

121.01

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

6968

27176

1.39

119.82

2.4

2.7

1.8

1.7

2.99

6056

24237

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1786

5038

1.89

118.22

1.2

1.3

mmol/l

3.8

3.7

1.67

1684

4731

(3009542) Hematocrit [Volume Fraction] of Blood

53787

268030

1.26

116.06

17.4

12.8

40.0

40.1

3.67

38719

203300

(3013139) Helicobacter pylori Ag [Presence] in Stool

4597

16763

1.48

113.65

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

9403

38730

1.32

113.15

2.0

2.2

29.7

29.9

2.12

9108

37622

(40761536) Microorganisms panel - Urine sediment

5824

22284

1.41

111.39

4.2

3.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2267

7012

1.73

111.32

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2290

7107

1.72

111.13

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2283

7086

1.72

110.74

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4140

14866

1.50

110.25

6.4

7.4

mmol/l

24.9

24.6

5.69

4088

14749

(3022217) INR in Platelet poor plasma by Coagulation assay

7926

32014

1.34

108.59

21.9

24.2

inr

1.3

1.4

3.53

1142

4656

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2407

7651

1.68

107.08

1.9

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2662

8692

1.64

106.92

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

14639

64226

1.25

106.72

2.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3028

10230

1.58

105.93

1.1

u/ml

1.1

12.2

1.91

146

(3016502) Oxygen saturation in Arterial blood

6298

24634

1.38

105.56

7.6

7.8

95.2

95.9

10.51

6079

23646

(3010421) pH of Blood

2012

6107

1.76

105.39

3.9

3.7

7.4

3.81

1729

5215

(3020961) Endomysium IgA Ab [Titer] in Serum

3539

12559

1.51

99.37

1.1

titre

146.3

207.1

0.66

392

(1616796) Gas panel - Central venous blood

1768

5256

1.79

99.21

3.4

3.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

16593

74299

1.23

99.15

3.5

3.0

—

(3027315) Oxygen [Partial pressure] in Blood

1791

5357

1.78

98.49

4.0

3.7

kpa

8.8

8.7

0.77

1740

5242

(3012501) Base excess in Blood by calculation

1780

5323

1.78

97.95

3.9

3.7

mmol/l

2.5

2.4

0.40

1214

3520

(3013290) Carbon dioxide [Partial pressure] in Blood

1780

5324

1.78

97.89

3.9

3.7

kpa

5.1

5.0

6.98

1729

5209

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3457

12266

1.51

97.08

2.4

2.3

u/l

5577.9

6530.6

0.88

1192

5340

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

654

1328

2.61

94.62

1.7

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

1629

4807

1.80

93.62

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

15521

69362

1.23

93.41

2.5

2.6

umol/l

3326.4

4541.5

3.65

13273

61057

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4597

17389

1.42

92.96

2.3

au/ml

24.9

23.2

0.34

245

1119

(3008295) Osmolality of Serum or Plasma

851

1980

2.28

92.81

1.6

1.5

mosm/kgh2o

280.5

280.6

0.02

663

1586

(3005322) IgE [Units/volume] in Serum or Plasma

4460

16790

1.43

92.60

1.3

u/ml

300.4

249.6

0.88

4096

15584

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1662

4955

1.78

92.36

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1661

4952

1.78

92.30

1.3

—

(3019060) Gas panel - Arterial blood

4155

15451

1.44

92.16

4.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

4975

19172

1.39

90.37

2.3

2.8

g/l

10.5

10.7

2.59

4493

17672

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4219

15841

1.43

88.73

1.3

au/ml

40.8

50.3

1.52

142

676

(3003181) Sodium [Moles/volume] in Urine

1254

3466

1.92

88.05

1.4

mmol/l

60.9

65.0

2.34

948

2804

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5195

20291

1.38

86.91

2.3

2.2

ug/l

6.5

7.8

3.88

4372

17888

(40761535) Cells panel - Urine sediment

5164

20164

1.38

86.53

3.5

3.3

—

(3007463) Buprenorphine [Presence] in Urine

29.14

85.15

7.3

4.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2728

9462

1.54

84.81

1.6

1.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

180

141

6.73

84.39

6.2

8.9

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5731

22862

1.35

83.75

8.1

8.2

g/l

122.7

121.7

2.78

5539

21996

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4601

17725

1.39

83.46

3.5

4.2

ng/l

85.8

94.0

6.43

3937

15445

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2749

9604

1.53

82.68

1.2

u/ml

0.8

0.9

0.29

228

814

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

27375

130121

1.18

81.84

4.0

3.9

—

(3052851) Hemolysis interference index of Serum or Plasma

2204

7340

1.60

81.52

3.3

3.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

2094

6913

1.61

80.24

1.2

1.3

titre

78.9

129.8

3.80

192

654

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

505

977

2.73

80.03

1.9

1.4

iu/ml

2231125.0

1686166.2

0.34

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3430

12647

1.45

79.21

8.8

9.7

mmol/l

24.4

24.2

2.59

3164

11861

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1961

6406

1.63

78.35

1.3

—

(40768804) Tissue Pathology biopsy report

23325

109828

1.18

76.42

2.1

2.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3905

14873

1.40

75.42

1.8

1.9

g/l

1.3

0.17

3528

13647

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

549

1150

2.52

74.88

1.0

ng/l

773.1

733.1

0.98

361

799

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

547

1145

2.53

74.71

1.0

ng/l

290.4

370.7

1.69

369

834

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

549

1152

2.52

74.62

1.0

ng/l

42.0

43.3

0.18

361

829

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1828

5966

1.63

73.28

2.9

3.0

mmol/l

24.7

24.4

2.83

1621

5237

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1280

3788

1.79

72.86

1.4

1.3

u/l

22.2

25.6

3.08

1024

3206

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3020

11048

1.46

72.51

3.1

2.9

1.4

1.2

17.62

3003

10991

(40767503) Oxygen content in Capillary blood by calculation

1588

5024

1.68

71.68

2.5

2.4

16.7

16.5

0.71

820

2576

(3034770) Mitochondria Ab [Titer] in Serum

2023

6806

1.58

71.66

1.2

titre

819.7

1087.2

0.73

200

(3020891) Body temperature

2582

9189

1.50

71.06

5.1

4.8

—

(3023520) Reticulocytes [#/volume] in Blood

5014

20093

1.34

70.50

2.3

2.8

e9/l

71.9

68.6

6.88

3684

15218

(3028271) Lactate [Moles/volume] in Capillary blood

1241

3679

1.79

70.24

2.0

1.8

mmol/l

1.8

1.7

0.21

1219

3580

(3020779) Urea [Moles/volume] in Serum or Plasma

5462

22179

1.32

70.13

6.6

8.0

mmol/l

8.9

10.0

24.68

5156

21113

(21494755) Public health laboratory ask at order entry panel

5080

34458

0.76

69.73

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

11199

49673

1.22

69.16

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5444

22145

1.32

68.98

1.4

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1221

3622

1.79

68.97

1.6

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7347

31097

1.27

68.88

4.5

4.2

31.1

32.5

18.63

5140

21667

(3002179) Metamyelocytes/100 leukocytes in Blood

4929

19772

1.34

68.77

3.7

4.0

0.6

0.7

0.95

1035

4409

(3017181) Myelocytes/100 leukocytes in Blood

5366

21803

1.32

68.52

4.0

4.2

0.9

0.56

1430

6079

(3000492) Spirometry study

6363

26478

1.29

68.18

1.5

1.4

—

(3017732) Neutrophils [#/volume] in Blood

4602

18299

1.35

68.04

3.3

2.5

e9/l

4.1

0.07

3524

14409

(3028626) Oxygen [Partial pressure] in Capillary blood

1690

5525

1.63

67.28

2.8

3.1

kpa

8.3

8.4

1.15

1576

5130

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

743

1871

2.10

67.21

1.7

2.4

nmol/l

19.6

19.8

0.27

682

1795

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3894

15113

1.38

67.07

9.0

9.3

1.5

1.3

15.49

3872

15003

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2932

10845

1.44

66.36

3.1

2.9

0.7

0.03

2817

10438

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3886

15105

1.38

66.29

9.0

9.4

0.7

0.11

3863

15009

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

191

210

4.80

65.96

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3884

15154

1.37

64.69

9.1

9.5

93.4

94.1

9.43

3867

15101

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2740

10053

1.45

64.68

1.6

mg/l

3.5

3.6

0.28

2090

6587

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

897

2468

1.93

63.90

1.3

nmol/l

24.9

32.5

0.54

(3021440) Promyelocytes/100 leukocytes in Blood

5101

20785

1.32

63.62

4.0

4.2

0.1

1.49

1319

5673

(3004588) Protein electrophoresis panel - Serum or Plasma

3968

15577

1.36

63.57

2.2

2.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3309

12634

1.40

62.72

2.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1156

3475

1.76

62.51

1.4

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

464

982

2.50

62.11

1.3

nmol/l

141.5

135.0

1.76

464

982

(3016650) Hepatitis A virus Ab [Presence] in Serum

1342

4244

1.68

60.68

1.1

—

(3021901) Oxygen saturation in Capillary blood

1356

4317

1.67

59.80

2.6

2.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7341

31559

1.25

59.71

1.7

1.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3810

15009

1.36

59.59

7.4

6.9

mmol/l

24.8

24.4

8.48

3575

13935

(3018405) Lactate [Moles/volume] in Arterial blood

2257

8115

1.48

58.98

4.3

4.1

mmol/l

1.4

0.17

2225

7960

(3025159) Blasts/100 leukocytes in Blood

4794

19622

1.31

57.64

4.1

4.2

0.1

0.3

4.12

1111

4813

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1314

4200

1.66

57.10

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4751

19449

1.31

57.04

2.3

2.6

g/l

66.7

66.6

0.44

4274

17812

(3023410) Appearance of Cerebral spinal fluid

832

2329

1.89

56.40

1.5

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3696

14692

1.34

54.37

3.5

3.4

g/l

131.0

129.3

4.13

3598

14374

(3004716) Salmonella sp identified in Stool by Organism specific culture

3667

14631

1.34

52.58

1.3

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

963

2902

1.76

51.71

1.4

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1547

5285

1.55

51.28

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

989

3015

1.74

51.05

1.9

1.7

89.8

90.1

0.57

972

2966

(3016018) Differential panel - Cerebral spinal fluid

870

2561

1.80

50.50

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4805

20010

1.28

50.42

2.8

2.9

ng/l

170.3

216.4

10.90

4314

18220

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

766

2192

1.85

48.65

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

1933

7013

1.46

48.24

4.5

4.4

mmol/l

3.8

3.9

5.26

1808

6599

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1250

4124

1.61

48.02

1.5

nmol/l

0.3

0.4

2.79

957

3328

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2505

9550

1.40

47.71

1.9

1.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2062

7594

1.44

47.61

1.1

u/ml

2.7

6.5

7.50

257

1040

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2714

10504

1.37

47.23

2.0

1.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1610

5664

1.51

46.72

2.2

g/l

132.1

130.6

1.47

1197

4135

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2421

9224

1.40

46.27

1.3

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

583

1553

1.98

45.66

3.3

3.2

mu/l

29.5

25.4

1.43

544

1451

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6691

29269

1.23

45.51

3.5

4.5

u/l

236.3

245.0

4.00

6251

27822

(3024928) Oxygen saturation in Venous blood

1433

4976

1.53

44.19

3.2

3.5

—

(3008898) HLA-B27 [Presence]

2420

9293

1.38

44.14

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4661

30181

0.80

42.27

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1904

7075

1.43

41.90

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

709

2083

1.80

41.52

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

872

2748

1.68

40.08

9.1

5.8

mmol/l

7.3

7.4

0.10

714

2228

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1660

6075

1.45

39.64

2.2

2.3

g/l

0.0

0.37

1488

5557

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

400

975

2.17

39.47

2.6

2.5

umol/l

56.0

53.9

0.60

333

803

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2101

8038

1.39

39.17

1.7

g/l

1.2

7.92

1989

7654

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

115

129

4.70

39.10

1.1

1.4

mg/l

58.0

43.5

1.44

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1970

7463

1.40

38.91

2.3

2.5

g/l

0.7

0.9

2.31

1693

6414

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2045

7801

1.39

38.79

1.7

g/l

0.2

2.23

1936

7393

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

627

1819

1.82

38.28

1.1

mg/l

283.7

451.0

0.52

552

1650

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2705

10807

1.33

38.25

4.2

3.9

50.2

47.6

6.11

2665

10700

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

957

3132

1.62

38.07

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1631

5996

1.44

38.03

2.2

2.3

g/l

0.0

0.00

1481

5545

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1807

6781

1.41

37.67

2.2

g/l

37.9

37.6

0.73

1563

5839

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

934

3049

1.62

37.54

1.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

376

914

2.17

37.39

1.4

72.9

72.6

0.14

358

872

(3003338) MCHC [Mass/volume]

49316

250627

1.13

37.32

21.1

15.1

g/l

332.8

333.0

2.32

48886

248558

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1764

6603

1.42

37.29

2.2

2.3

g/l

0.0

0.25

1588

6061

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

511

1400

1.93

37.10

1.3

1.2

umol/l

5.3

0.00

463

1310

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

998

3328

1.59

36.79

1.9

1.8

titre

6613.9

2943.6

0.73

146

(3024522) Salmonella sp identified in Specimen by Organism specific culture

933

3061

1.61

36.77

1.4

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

368

897

2.17

36.37

1.5

1.4

mu/l

521.0

751.7

0.87

350

855

(3027273) Bicarbonate [Moles/volume] in Venous blood

2896

11766

1.31

36.36

3.6

3.4

mmol/l

25.4

25.2

2.75

2797

11416

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2031

7826

1.38

36.27

1.9

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

919

3018

1.61

36.08

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

916

3015

1.61

35.64

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

916

3016

1.61

35.60

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

3586

15032

1.27

35.35

1.7

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2691

10883

1.31

34.92

1.9

2.0

u/l

39.3

39.4

0.04

2406

9717

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

988

3336

1.57

34.58

1.3

nmol/l

0.2

0.3

1.88

191

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

611

1817

1.78

34.49

1.3

1.2

mmol/l

2.0

2.1

1.62

569

1684

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2122

8316

1.35

34.10

2.2

2.3

g/l

3.0

3.1

0.73

1679

6451

(3017509) Phencyclidine [Presence] in Urine

161

264

3.22

33.91

2.2

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1250

4469

1.48

33.65

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2109

8274

1.35

33.65

2.2

2.3

g/l

10.1

10.4

2.02

1775

6928

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1666

6314

1.40

32.85

1.2

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

983

3357

1.55

32.78

1.3

nmol/l

1.0

1.4

0.23

941

3237

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1019

3513

1.53

32.58

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1810

6969

1.38

32.49

1.2

1.3

u/ml

38.6

38.0

0.03

434

(3016038) Potassium [Moles/volume] in Urine

467

1304

1.89

32.16

1.2

1.3

mmol/l

32.2

35.5

2.09

379

1156

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

320

778

2.17

31.91

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2227

8890

1.33

31.66

2.1

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2229

8901

1.33

31.61

2.1

2.3

g/l

7.4

0.29

1725

6581

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2367

9543

1.32

31.40

2.0

ug/l

2.1

2.4

0.38

2067

8457

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

314

763

2.17

31.36

2.9

3.0

umol/l

28.8

28.9

0.05

226

595

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2221

8880

1.33

31.23

2.1

2.3

g/l

3.8

3.9

0.85

1644

6284

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1672

6406

1.38

30.94

1.8

1.9

iu/l

9.3

19.8

0.49

589

2412

(3036180) Methadone [Presence] in Urine

41.27

30.54

3.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

312

766

2.15

30.41

1.7

2.6

ug/l

1.1

0.12

289

723

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

311

764

2.15

30.27

1.4

pmol/l

13.8

15.5

4.61

256

661

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

893

3041

1.55

30.20

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

710

2290

1.64

30.04

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2730

11312

1.28

29.49

1.6

1.8

g/l

1.5

1.41

2290

9687

(3006270) Folate [Moles/volume] in Blood

618

1935

1.69

29.26

1.2

1.1

nmol/l

378.8

357.7

1.59

531

1637

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1374

5140

1.42

29.22

1.2

u/ml

34.4

45.8

1.71

126

501

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2699

11190

1.28

29.02

1.4

1.6

u/ml

16.6

14.0

0.34

370

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

448

1282

1.84

28.72

1.1

nmol/l

3.1

6.7

1.23

263

(3048929) Epstein Barr virus Ab [Presence] in Serum

2390

9768

1.30

28.70

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

283

685

2.18

28.59

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

7.62

28.52

2.2

1.9

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

8.39

28.21

1.1

mmol/l

—

(3011985) Renin [Units/volume] in Plasma

943

3303

1.51

28.11

1.5

1.6

mu/l

68.1

58.3

0.75

834

2982

(40768443) Skin Pathology biopsy report

2702

11264

1.27

27.81

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

3156

20381

0.81

27.43

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

544

1677

1.71

27.28

1.1

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

540

1668

1.71

26.90

1.1

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3174

13547

1.24

26.71

9.6

9.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

9619

45219

1.14

26.34

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

620

2004

1.63

26.10

1.2

1.1

mg/l

37.4

47.0

4.35

519

1701

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2154

8798

1.30

26.00

1.6

titre

239.7

290.0

0.47

367

(3013005) Retinol [Moles/volume] in Serum or Plasma

355

977

1.92

25.65

1.7

1.8

umol/l

2.0

1.9

0.58

327

924

(3036489) Thrombin time

2439

10141

1.28

25.64

1.9

2.2

21.3

21.5

0.71

2114

8797

(3024980) IgG subclass 4 [Mass/volume] in Serum

1131

4185

1.43

25.61

1.4

1.6

g/l

0.7

0.8

2.57

835

3166

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

950

3401

1.48

25.53

1.1

g/l

1.5

0.60

842

3097

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4691

20924

1.19

25.39

2.6

ml/min/173m2

70.6

66.5

8.53

1859

8084

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

598

1932

1.63

25.24

1.1

mg/l

250.9

276.5

1.64

529

1719

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

343

939

1.93

25.18

2.6

2.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1839

7397

1.32

24.84

1.9

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

427

1268

1.78

24.41

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1642

6517

1.33

24.34

1.3

u/ml

6.4

9.7

1.77

268

1025

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

435

1301

1.76

24.29

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1449

5647

1.36

24.21

1.5

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

846

2993

1.49

24.13

2.0

mg/l

25.5

27.4

0.41

229

776

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

577

1870

1.63

24.09

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

426

1270

1.77

24.05

1.2

u/l

344.7

339.3

0.03

395

1192

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2982

19068

0.82

23.48

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1489

5862

1.34

23.32

1.5

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

859

3072

1.48

23.26

1.3

1.4

pmol/l

353.3

283.5

1.17

664

2394

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1770

7149

1.31

23.23

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1614

6435

1.33

23.21

1.3

u/ml

4.0

7.6

1.59

171

687

(4027681)

488

1529

1.68

23.18

1.3

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

638

2140

1.57

23.17

1.4

1.3

nmol/l

1.5

1.4

2.21

569

1943

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1323

5137

1.36

22.66

2.1

nmol/l

0.9

0.8

2.76

1088

4332

(3014271) Vancomycin [Susceptibility]

366

1062

1.82

22.61

3.2

2.8

—

(3037121) Protein [Mass/volume] in Urine

2136

8876

1.28

22.58

3.0

3.3

g/l

0.3

0.50

922

4153

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3197

13901

1.22

22.57

2.7

e6/l

0.3

0.51

3104

13537

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

391

1159

1.78

22.54

1.2

1.3

67.9

64.1

0.27

140

(3045414) Leukocytes [Presence] in Urine

2719

11696

1.23

21.30

1.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

975

3636

1.42

21.24

1.4

—

(4146454)

709

2494

1.50

20.87

2.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

358

1059

1.78

20.83

1.7

1.6

nmol/l

4.7

5.9

0.19

285

903

(3022621) pH of Urine by Test strip

3897

17404

1.19

20.72

3.1

2.7

—

(3019230) Fractional oxyhemoglobin in Venous blood

1088

4157

1.38

20.62

3.3

3.1

63.7

65.6

1.96

1082

4140

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

408

1258

1.71

20.61

1.6

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1093

4180

1.38

20.60

1.6

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

853

3127

1.44

20.42

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2309

9810

1.25

20.26

1.3

miu/ml

230.3

226.4

0.18

996

4672

(3027135) IgG subclass 1 [Mass/volume] in Serum

737

2631

1.48

20.22

1.3

1.4

g/l

6.4

6.9

2.77

509

1823

(3024139) IgG subclass 3 [Mass/volume] in Serum

736

2628

1.48

20.17

1.3

1.4

g/l

0.4

2.16

511

1824

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1268

8806

0.75

20.07

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1112

4285

1.37

20.03

1.5

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1326

5252

1.34

20.01

1.2

u/ml

11.9

15.1

0.12

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1747

7193

1.29

19.91

1.4

1.5

iu/ml

16.7

12.6

0.48

171

(3028192) IgG subclass 2 [Mass/volume] in Serum

735

2631

1.48

19.90

1.3

1.4

g/l

2.9

3.0

1.51

510

1824

(4062490)

735

2633

1.47

19.83

1.3

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1876

7799

1.27

19.80

1.4

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

765

2765

1.46

19.73

1.0

1.1

—

(3047181) Lactate [Moles/volume] in Blood

1901

7927

1.27

19.58

5.9

5.6

mmol/l

1.3

0.94

1676

6986

(3012920) Ethanol [Mass/volume] in Serum or Plasma

6.80

19.15

1.5

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

257

702

1.93

19.15

1.2

18.1

20.4

0.15

120

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

883

3298

1.41

19.13

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

7337

34553

1.13

19.07

1.8

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

654

2307

1.50

19.05

1.4

1.3

pmol/l

108.5

116.5

0.05

257

616

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

171

400

2.25

18.93

1.4

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1141

4459

1.35

18.84

3.0

3.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

384

1195

1.70

18.83

1.1

u/ml

7.8

11.1

0.94

214

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

767

2802

1.45

18.75

1.1

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1268

5040

1.33

18.72

1.1

u/ml

1.1

0.02

555

2154

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1684

6962

1.28

18.61

2.0

2.1

mg/l

11.1

10.9

0.22

1579

6515

(3029634) Reagin Ab [Titer] in Serum by VDRL

1074

4167

1.36

18.58

2.3

2.1

titre

6.8

6.7

0.02

114

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

859

3212

1.41

18.51

6.5

6.2

mg/l

11.4

11.5

0.24

780

2956

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1325

5310

1.32

18.48

1.2

u/ml

2.3

6.2

2.69

436

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

421

1350

1.65

18.47

1.4

1.5

u/l

5.8

6.0

0.14

352

1133

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

536

1824

1.55

18.43

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

184

450

2.16

18.36

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

314

933

1.77

18.09

1.7

1.8

umol/l

28.6

28.7

0.07

302

902

(3041806) Other cells [#/volume] in Blood by Manual count

395

1254

1.66

18.02

1.5

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1451

5914

1.30

17.91

1.1

u/ml

1.8

0.03

610

2400

(3006922) Hepatitis E virus Ab [Presence] in Serum

537

1841

1.54

17.89

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

775

5689

0.71

17.77

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1952

8261

1.25

17.77

2.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

445

1463

1.60

17.72

1.3

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1316

5307

1.31

17.58

1.1

u/ml

5.4

6.1

0.75

709

2771

(3023419) Bacteria identified in Sputum by Culture

777

2889

1.42

17.32

2.4

2.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

371

1173

1.67

17.22

1.6

1.5

umol/l

20.1

26.6

4.35

352

1121

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1864

7884

1.25

17.07

2.2

2.7

187.3

185.4

0.39

1757

7492

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

436

1443

1.59

16.92

1.3

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

649

4867

0.70

16.92

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

384

1235

1.64

16.72

2.0

2.2

umol/l

13.8

27.4

1.77

107

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

209

558

1.97

16.68

1.3

1.2

nmol/l

125.3

128.3

0.09

146

429

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

416

1366

1.61

16.68

1.1

u/l

1.0

1.1

1.07

185

629

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

497

1703

1.54

16.64

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

473

1604

1.56

16.58

1.4

1.6

u/ml

25.6

25.1

0.05

103

313

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

498

1714

1.53

16.35

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

207

558

1.96

16.11

1.4

1.3

umol/l

16.5

0.04

179

505

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1429

9496

0.79

16.08

1.5

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2355

10278

1.21

16.07

5.3

4.8

1.8

1.6

9.22

2206

9627

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

252

727

1.83

16.04

1.1

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

415

1379

1.59

15.88

1.2

1.3

titre

423.2

391.2

0.05

104

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1421

5871

1.28

15.85

1.2

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

401

1323

1.60

15.81

1.7

1.5

nmol/l

1.3

1.2

0.24

299

1081

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

403

1333

1.59

15.73

1.2

1.3

titre

70.6

82.7

0.25

113

(3019977) pH of Arterial blood

386

1265

1.61

15.65

3.1

2.3

7.4

0.72

115

428

(44813793)

534

1885

1.49

15.62

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

304

937

1.71

15.54

1.1

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1341

5525

1.28

15.31

1.2

1.3

u/ml

262.2

258.8

0.17

844

3580

(3044242) Glucose [Moles/volume] in Arterial blood

329

1042

1.67

15.24

2.3

1.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2004

8652

1.23

15.24

2.0

2.4

93.5

91.7

2.48

1847

8087

(3007930) Methemoglobin/Hemoglobin.total in Blood

2307

10102

1.21

15.23

5.4

4.9

0.9

0.14

2171

9457

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

344

1103

1.64

15.21

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

344

1103

1.64

15.21

1.3

1.4

—

(4094501)

1611

6812

1.25

14.85

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

508

1802

1.49

14.55

2.8

2.2

—

(3042631) Mycobacterium sp identified in Specimen

834

3236

1.36

14.55

2.7

2.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1463

6134

1.26

14.51

2.3

2.5

ug/min

110.4

114.1

0.10

856

3763

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1220

5003

1.29

14.48

1.2

titre

144.5

132.6

0.07

106

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1216

4986

1.29

14.45

1.1

u/ml

1.9

2.2

0.34

307

1246

(3028717) Thiamine [Mass/volume] in Blood

205

2.54

14.30

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2930

13184

1.18

14.29

2.9

3.3

u/ml

54.4

50.4

0.14

2819

12749

(3032057) Clostridioides difficile [Presence] in Stool

169

443

2.01

14.27

1.8

1.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

867

3397

1.35

14.22

1.5

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

792

3066

1.36

14.04

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

236

697

1.78

14.02

3.0

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

236

697

1.78

14.02

3.0

2.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1731

7439

1.23

13.80

3.0

3.4

mg/l

38.3

46.1

1.32

1374

6063

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

714

2726

1.38

13.79

1.5

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

686

2602

1.39

13.78

1.4

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2004

12640

0.83

13.71

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1731

7446

1.23

13.68

3.0

3.4

mg/l

52.1

66.5

1.01

1378

6064

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

133

323

2.17

13.65

1.1

1.0

ug/l

79.8

81.0

0.12

114

266

(3008116) Ketones [Moles/volume] in Urine by Test strip

169

451

1.97

13.62

1.4

1.3

—

(4024509)

612

2286

1.41

13.44

1.6

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

947

3792

1.32

13.44

1.3

—

(3002256) Pathology report gross observation

7310

35080

1.11

13.41

1.3

—

(3001556) Androgen free Index in Serum or Plasma

123

292

2.22

13.33

1.3

1.2

—

(3051651) Icteric interference index of Serum or Plasma

427

1493

1.51

13.17

3.9

4.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2048

8994

1.20

13.17

1.4

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1679

7234

1.23

13.08

3.0

3.4

ratio

5.7

4.5

0.11

122

570

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

518

1892

1.44

12.87

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

492

1780

1.46

12.85

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1114

4598

1.28

12.64

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

506

1847

1.45

12.63

1.3

1.4

umol/l

11.7

12.4

1.71

470

1769

(3051611) Lipemic interference index of Serum or Plasma

675

2593

1.37

12.62

3.5

3.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

577

2161

1.41

12.52

1.2

titre

179.8

200.4

0.23

101

362

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1103

7330

0.79

12.51

1.4

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

504

1843

1.44

12.47

1.2

1.3

u/ml

1.4

1.3

0.09

229

805

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

172

2.57

12.46

1.5

1.3

pmol/l

10.7

16.0

0.79

144

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

575

2157

1.41

12.37

1.2

titre

279.4

163.0

0.46

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

674

2599

1.37

12.32

1.2

u/l

59.7

65.9

0.86

461

1765

(3025130) Human papilloma virus identified in Specimen

933

3781

1.30

12.20

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1034

4250

1.28

12.14

1.1

au/ml

12.1

12.0

0.01

308

(3049717) Cytology report of Urine Cyto stain

2130

9461

1.19

12.13

2.5

2.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

459

1660

1.46

12.05

1.9

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1658

10513

0.83

12.05

1.4

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

193

563

1.81

12.02

1.1

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

411

1455

1.49

12.00

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

471

1717

1.45

11.88

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

370

1285

1.52

11.84

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

371

1292

1.51

11.73

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

231

717

1.70

11.67

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1875

8281

1.20

11.40

2.5

2.7

g/l

3.7

3.6

1.03

1765

7921

(4034850)

1903

8427

1.19

11.24

10.6

8.8

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

108

2.93

11.24

1.2

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

1356

5811

1.23

11.19

2.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

594

2284

1.37

11.11

3.8

3.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

685

2700

1.34

10.94

3.1

3.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1012

4214

1.27

10.77

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

531

2018

1.39

10.68

1.1

u/ml

61.6

66.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

753

3022

1.31

10.64

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

197

602

1.72

10.58

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

146

407

1.89

10.52

1.5

nmol/l

0.2

0.13

114

303

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1023

4283

1.26

10.43

1.1

iu/ml

48.5

825.8

1.38

229

956

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

409

1491

1.45

10.39

1.5

1.4

—

(40768800) Prostate Pathology biopsy report

807

5438

0.78

10.37

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

279

939

1.57

10.34

1.1

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

972

4050

1.27

10.32

1.1

120.6

116.8

3.11

882

3682

(3017569) Oxygen content in Arterial blood

296

1011

1.54

10.29

2.5

2.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

151

430

1.85

10.22

1.5

1.4

nmol/l

5.8

6.9

0.55

142

415

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1877

8377

1.18

10.19

3.2

3.1

u/ml

0.3

0.35

1069

4721

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

612

2399

1.35

10.18

1.5

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

967

4037

1.26

10.11

1.3

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

980

4103

1.26

10.01

1.1

u/ml

2.3

3.1

1.55

451

2067

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

936

3904

1.27

9.88

1.2

1.3

u/l

32.7

36.2

0.26

803

3417

(3037756) Immunofixation for Serum or Plasma

1148

4903

1.24

9.85

1.5

1.7

—

(3021788) Differential panel - Synovial fluid

1081

4587

1.24

9.84

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

388

1416

1.44

9.83

1.4

1.5

ug/l

7.8

8.5

0.28

348

1283

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1568

9790

0.84

9.68

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1563

9758

0.84

9.65

1.4

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

518

1997

1.37

9.62

1.2

u/ml

41.3

38.4

0.07

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

192

601

1.68

9.52

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1574

9809

0.84

9.52

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1573

9802

0.84

9.50

1.4

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

193

607

1.68

9.41

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1038

4409

1.24

9.39

1.2

1.3

u/ml

3.4

3.7

0.18

350

1582

(3004809) Band form neutrophils/100 leukocytes in Blood

977

4126

1.25

9.30

2.8

3.4

1.4

1.5

0.40

753

3212

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1253

7948

0.83

9.25

1.4

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1004

4257

1.24

9.23

1.2

1.3

u/ml

3.7

4.0

0.30

428

1958

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

142

411

1.82

9.20

1.2

1.4

ng/l

99.5

289.7

0.50

288

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1636

7283

1.19

9.19

3.3

3.7

mg/l

1.5

1.77

1507

6736

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1281

5578

1.21

9.14

1.6

—

(3012565) Volume of 24 hour Urine

350

1271

1.45

9.14

1.9

2.2

1999.6

1972.2

0.17

314

1143

(3005033) Fetal Nuchal fold Thickness US

1252

7933

0.83

9.14

1.4

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

383

1415

1.43

9.13

1.2

1.3

u/l

27.7

24.8

0.35

321

1238

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1010

4292

1.24

9.11

1.1

u/ml

4.9

4.4

0.28

395

1724

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1285

8116

0.83

9.06

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

149

440

1.78

9.06

2.6

2.4

mmol/l

7.5

7.6

0.16

254

(3028679) Herpes simplex virus Ab [Presence] in Serum

412

1545

1.41

9.05

1.1

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

184

578

1.68

9.03

1.8

2.0

—

(3020491) Glucose [Moles/volume] in Blood

511

1988

1.36

9.00

1.8

1.7

mmol/l

7.0

6.5

2.11

376

1459

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

190

603

1.66

8.98

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

1284

5603

1.21

8.98

3.0

3.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

184

581

1.67

8.87

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

615

2465

1.32

8.87

2.8

3.4

57.8

58.5

0.29

384

1600

(3013247) Albumin in CSF/Albumin in Serum or Plasma

177

555

1.68

8.77

1.1

mg/g

6.9

7.3

0.23

170

526

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

941

3986

1.25

8.76

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

346

1266

1.44

8.72

1.2

1.1

iu/ml

3.5

3.9

0.37

104

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

178

560

1.67

8.71

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

500

1950

1.35

8.69

1.2

u/ml

79.9

67.8

0.32

(3016330) Potassium [Moles/time] in 24 hour Urine

126

359

1.85

8.60

1.3

mmol/24h

86.8

79.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

249

854

1.54

8.60

1.2

110.9

0.01

227

762

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

391

1467

1.41

8.59

1.2

1.3

u/l

95.7

92.0

0.24

338

1295

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1344

5919

1.20

8.55

1.3

1.5

u/ml

23.1

19.8

0.31

114

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

187

600

1.64

8.51

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

500

1957

1.35

8.50

1.2

u/ml

40.7

46.5

0.21

145

(3045716) Anion gap in Serum or Plasma

295

1052

1.48

8.49

2.3

2.4

mmol/l

9.2

9.1

0.06

214

768

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

158

485

1.72

8.46

1.3

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1012

4340

1.23

8.43

1.8

2.2

umol/l

5.4

6.9

2.60

723

3205

(3039000) Anion gap in Blood

1270

5572

1.20

8.42

7.1

6.6

mmol/l

11.3

0.05

1143

5003

(3018572) Chloride [Moles/volume] in Blood

1270

5573

1.20

8.41

7.1

6.6

mmol/l

105.0

105.3

1.25

1143

5005

(3023430) Cat dander IgE Ab [Units/volume] in Serum

942

4013

1.24

8.36

1.1

u/ml

6.2

4.8

0.87

401

1700

(3012494) Peanut IgE Ab [Units/volume] in Serum

234

797

1.55

8.35

1.1

u/ml

2.1

20.8

0.85

130

445

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

123

352

1.84

8.31

1.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

531

2106

1.33

8.28

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

531

2106

1.33

8.28

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

531

2106

1.33

8.28

1.5

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

778

3248

1.26

8.24

1.2

u/ml

55.5

51.2

0.14

220

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

400

1519

1.39

8.22

1.5

1.6

u/l

4.8

7.1

2.42

204

741

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

266

936

1.50

8.19

1.2

g/l

0.3

0.42

216

738

(3028433) Virus identified in Specimen by Culture

242

835

1.53

8.16

1.1

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1349

5971

1.19

8.15

1.3

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

857

3624

1.25

8.14

2.6

2.9

u/ml

1254.2

732.1

0.20

824

3430

(4306422)

987

4239

1.23

8.13

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

436

1683

1.37

8.12

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

478

1872

1.35

8.12

1.2

u/ml

4.4

11.4

1.52

121

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

577

2324

1.31

8.09

2.7

—

(3044927) Protein electrophoresis panel - Urine

565

2273

1.31

7.99

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

275

981

1.48

7.94

1.1

ng/l

472.2

459.6

0.01

233

(3010838) Calcium [Moles/time] in 24 hour Urine

317

1164

1.44

7.89

1.6

mmol/24h

6.0

5.4

0.38

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

108

302

1.88

7.85

1.0

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

187

614

1.60

7.82

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

581

2354

1.30

7.82

1.5

1.6

31.0

30.9

0.02

346

1542

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

377

1431

1.39

7.80

1.9

1.7

u/field

2.2

2.6

0.38

272

1013

(3018851) Theophylline [Moles/volume] in Serum or Plasma

167

2.21

7.71

1.6

1.7

umol/l

41.7

45.9

0.53

167

(21491868) Cryoglobulin [Mass/volume] in Serum

246

864

1.50

7.68

1.2

g/l

0.5

0.4

0.16

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2001

12033

0.87

7.67

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

126

374

1.77

7.62

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

470

1861

1.33

7.47

1.6

1.4

umol/l

68.2

71.7

0.45

165

(3029075) Extractable nuclear Ab panel - Serum

215

739

1.53

7.43

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

252

1.94

7.43

1.1

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1222

5410

1.19

7.41

1.4

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

170

553

1.62

7.41

1.2

pmol/l

430.8

300.2

0.65

114

410

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

281

1022

1.45

7.39

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

933

4027

1.22

7.38

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

376

1441

1.38

7.38

2.1

2.6

u/ml

906.3

1132.2

0.73

371

1422

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5285

25683

1.09

7.37

3.5

4.2

ug/l

17.9

26.4

1.40

4212

20501

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

257

1.93

7.33

1.1

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1238

5500

1.19

7.23

1.3

1.5

u/ml

106.9

112.4

1.11

254

1211

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

159

513

1.63

7.17

1.5

1.6

ug/l

0.4

0.08

113

333

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

493

1981

1.31

7.10

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

492

1977

1.31

7.09

1.1

1.2

—

(4015189)

181

605

1.58

7.08

2.5

2.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

186

626

1.57

7.07

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

497

2001

1.31

7.06

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

496

1997

1.31

7.05

1.1

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1348

6049

1.18

7.01

1.6

1.7

e6/l

14605.8

13702.0

0.21

960

4457

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

496

1999

1.31

7.00

1.1

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

712

3003

1.25

7.00

1.1

96.9

95.4

0.71

670

2817

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

809

3462

1.23

6.97

1.0

u/ml

0.6

0.4

0.42

196

694

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

492

1982

1.31

6.97

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

893

3864

1.22

6.93

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

435

3000

0.76

6.89

1.6

mmol/l

8.1

7.5

3.89

253

1752

(3051339) Copper [Moles/volume] in Blood

108

2.44

6.87

1.2

1.4

umol/l

16.8

16.0

0.49

(3010015) Selenium [Moles/volume] in Serum or Plasma

177

2.08

6.76

2.2

2.0

umol/l

1.3

0.07

158

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

580

2401

1.27

6.69

3.8

5.1

u/ml

48.0

122.1

4.44

154

800

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

108

320

1.78

6.63

1.3

45.4

54.4

0.86

155

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

318

1211

1.38

6.55

2.2

2.1

ug/min

105.8

81.9

0.31

283

(44790049)

668

2821

1.25

6.53

1.4

1.6

—

(44806118)

668

2822

1.25

6.51

1.4

1.6

—

(44790047)

668

2822

1.25

6.51

1.4

1.6

—

(44790048)

668

2823

1.25

6.49

1.4

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

402

1591

1.33

6.48

1.9

2.2

99.2

96.6

0.73

369

1485

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

440

1767

1.31

6.42

1.1

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

138

444

1.64

6.35

1.1

umol/24h

0.6

3.9

0.50

219

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1886

8746

1.14

6.34

1.6

iu/ml

2.9

7.9

0.70

368

1867

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

392

2708

0.76

6.33

1.4

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

243

888

1.44

6.32

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

118

365

1.70

6.29

1.2

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

407

1624

1.32

6.23

3.1

3.5

nmol/l

104.4

141.0

1.82

399

1598

(44806071)

114

351

1.71

6.18

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

240

879

1.44

6.18

1.1

93.1

89.8

0.83

104

424

(3006576) Bicarbonate [Moles/volume] in Blood

238

871

1.44

6.16

5.4

6.3

mmol/l

24.9

25.0

0.18

222

784

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

235

858

1.44

6.15

1.1

94.6

89.6

0.98

107

414

(3005011) Chlamydia sp Ab [Titer] in Serum

114

352

1.71

6.12

1.7

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

217

783

1.46

6.05

1.4

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

720

3095

1.23

6.02

2.0

2.3

32.7

32.8

0.04

713

3071

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1304

5921

1.16

5.93

1.5

1.4

pmol/l

118.7

128.7

0.33

1270

5778

(3004451) EKG impression Narrative

293

1121

1.38

5.92

1.2

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

292

1117

1.38

5.90

3.9

—

(3024869) Neuronal Ab [Presence] in Serum

123

393

1.65

5.85

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

104

2.33

5.81

1.2

umol/24h

1.1

1.0

0.10

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

241

895

1.42

5.79

1.1

1.2

111.5

106.4

1.09

214

809

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

416

1685

1.30

5.76

1.1

iu/ml

6.9

8.3

0.62

455

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

474

1962

1.27

5.57

2.5

2.6

e6/l

803.9

693.8

0.89

177

800

(3045424) Erythrocytes [Presence] in Urine

1007

4504

1.18

5.56

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1470

6768

1.15

5.55

1.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

272

1.76

5.51

2.6

3.4

umol/l

40.7

43.8

0.67

223

(3034891) Synovial lining cells/100 cells in Synovial fluid

306

1194

1.35

5.50

1.5

4.1

4.4

0.09

307

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

123

400

1.62

5.50

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

270

1033

1.38

5.49

1.1

—

(4268621)

677

2928

1.22

5.39

2.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

511

2144

1.26

5.38

1.8

2.0

g/24h

1.1

1.0

0.18

126

(3011412) CD3 cells [#/volume] in Blood

610

2612

1.23

5.36

2.4

e9/l

1.2

1.1

1.05

357

1574

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

237

1.80

5.28

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

131

2.09

5.16

1.1

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

643

2781

1.22

5.15

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

143

491

1.53

5.13

1.3

mu/l

93.2

71.0

0.49

101

370

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

910

4069

1.18

5.09

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

724

3174

1.20

5.05

1.1

iu/ml

1.4

2.2

1.66

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.08

5.05

1.7

1.4

—

(40757373) Influenza virus identified in Isolate

138

473

1.54

5.00

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1286

5914

1.15

4.99

4.0

3.0

mg/l

27.0

27.2

0.05

782

3781

(21494815) CD4 cells/100 lymphocytes in Specimen

556

2381

1.23

4.92

2.3

2.1

43.8

39.2

1.67

287

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

988

4461

1.17

4.92

1.2

—

(3003129) Base excess in Capillary blood by calculation

166

595

1.47

4.88

1.6

mmol/l

0.7

0.2

0.74

160

559

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.63

4.88

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

584

2518

1.22

4.85

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1960

9274

1.12

4.83

1.4

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

+∞

4.78

1.0

0.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

165

1.91

4.75

1.3

1.4

41.0

36.2

0.31

108

(3002619) Bacteria identified in Specimen by Culture

142

496

1.51

4.74

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

705

4407

0.84

4.67

3.4

2.3

13.2

13.1

0.76

698

4349

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

142

498

1.50

4.66

1.1

u/ml

1.6

7.6

1.80

100

350

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

17346

88546

1.04

4.66

4.5

4.7

ug/l

2.6

3.4

2.22

15254

80106

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

138

1.98

4.56

1.2

1.1

u/field

1.1

1.2

0.44

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

206

1.79

4.54

1.5

1.6

mg/l

2.6

1.5

0.77

131

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

490

2091

1.24

4.52

2.1

1.9

u/field

2.0

2.3

0.40

243

886

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

267

1.68

4.42

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.97

4.41

1.4

3.3

mu/l

2.6

2.4

0.06

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

213

1513

0.74

4.36

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

647

2851

1.20

4.35

3.1

3.3

nmol/l

6.0

8.1

0.47

626

2772

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

414

1746

1.25

4.28

1.2

1.1

ratio

1.1

0.07

152

610

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

124

432

1.51

4.24

2.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

312

1273

1.29

4.23

1.8

2.0

134.0

142.3

1.23

288

1199

(3010370) Gastrin [Moles/volume] in Serum or Plasma

111

378

1.55

4.21

1.7

pmol/l

36.0

50.6

1.19

314

(3027456) Digoxin [Moles/volume] in Serum or Plasma

953

4349

1.16

4.20

3.3

3.0

nmol/l

0.8

0.03

698

3363

(3023420) DNA double strand Ab [Units/volume] in Serum

667

2958

1.19

4.19

1.6

iu/ml

28.5

36.0

0.69

134

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

450

1921

1.23

4.18

2.2

2.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

232

1.70

4.15

1.1

1.2

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

201

1.76

4.12

1.5

1.6

mg/l

2.0

2.9

0.62

145

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

201

1.76

4.12

1.5

1.6

mg/l

2.5

2.0

0.34

137

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

201

1.76

4.12

1.5

1.6

mg/l

2.2

2.0

0.10

133

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

201

1.76

4.12

1.5

1.6

mg/l

2.7

1.9

0.49

145

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

201

1.76

4.12

1.5

1.6

mg/l

1.9

1.8

0.11

143

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

201

1.76

4.12

1.5

1.6

mg/l

2.0

1.4

0.40

120

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

201

1.76

4.12

1.5

1.6

mg/l

1.2

0.7

0.68

129

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

201

1.76

4.12

1.5

1.6

mg/l

3.8

4.3

0.19

129

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

201

1.76

4.12

1.5

1.6

mg/l

2.7

1.7

0.59

121

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

213

1.73

4.10

1.2

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

144

1.90

4.09

1.4

1.5

14.8

12.3

0.25

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

313

1288

1.28

4.00

1.1

miu/ml

1678.5

1482.5

2.16

313

1288

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

441

1889

1.23

3.99

2.4

2.5

e6/l

532.9

534.4

0.02

352

1598

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

312

1284

1.28

3.98

1.1

u/l

79.7

87.7

0.95

246

1024

(3027231) Wheat IgE Ab [Units/volume] in Serum

149

548

1.43

3.93

1.1

1.0

u/ml

0.9

2.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

941

4315

1.15

3.91

2.5

3.0

u/ml

727.3

4785.6

1.04

252

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

316

1306

1.27

3.91

1.1

1.2

u/ml

10.6

11.4

0.04

143

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

311

1283

1.28

3.91

1.1

u/l

21.4

26.6

0.88

235

990

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

323

1.57

3.87

1.2

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

125

1.94

3.84

1.3

1.4

0.8

2.1

1.17

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1229

5744

1.13

3.84

4.6

6.0

iu/ml

1023.7

1193.5

0.14

126

900

(3000012) Reticulocyte production index

323

1345

1.27

3.78

1.4

1.5

—

(1761868) Lipid panel - Serum or Plasma

19656

106042

0.97

3.78

2.8

2.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.41

3.77

1.1

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

712

3213

1.17

3.69

1.5

1.6

58.1

56.9

0.30

436

2145

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

303

1256

1.27

3.69

1.0

1.1

99.8

96.5

0.98

245

1010

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

248

1002

1.30

3.68

1.7

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

248

1003

1.30

3.65

1.7

2.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

154

1.81

3.65

1.0

u/ml

23.2

19.7

0.13

131

(1175426) CD3 cells/100 lymphocytes in Blood

479

2092

1.21

3.62

2.1

73.8

72.5

1.16

453

2024

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

182

1.74

3.60

1.1

1.2

nmol/l

17.8

14.6

0.41

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

186

1.73

3.60

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

251

1020

1.30

3.58

1.7

2.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

292

1.57

3.58

1.0

u/ml

0.2

0.3

0.14

181

(3010503) CD19 cells [#/volume] in Blood

376

1605

1.23

3.57

2.7

2.5

e9/l

0.2

0.4

1.08

359

1574

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

145

1.82

3.48

1.2

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

261

1.59

3.48

1.0

u/ml

1.4

1.0

0.13

194

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

299

1.55

3.45

1.7

1.6

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

166

1.74

3.38

1.1

u/ml

1.3

3.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

170

1.73

3.38

1.1

u/l

8.2

11.5

0.90

170

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

174

1.72

3.37

1.3

1.2

23.5

26.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

182

1.71

3.37

1.0

u/ml

0.2

0.8

0.61

121

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

365

1564

1.23

3.37

2.7

2.8

40.5

38.8

0.60

118

534

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

148

561

1.39

3.37

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

314

1.53

3.34

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

179

701

1.34

3.33

1.6

ug/l

9.1

9.0

0.06

179

701

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

154

589

1.38

3.33

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

154

589

1.38

3.33

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

154

589

1.38

3.33

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

154

589

1.38

3.33

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

134

974

0.72

3.30

2.9

3.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

223

903

1.30

3.30

1.1

1.0

u/ml

7.6

12.4

1.10

116

(3011897) Casein IgE Ab [Units/volume] in Serum

115

418

1.45

3.30

1.1

1.2

u/ml

9.7

6.4

0.18

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

265

1.57

3.29

1.9

2.7

mmol/l

0.8

1.5

2.28

186

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

134

973

0.72

3.28

5.9

6.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

216

1.63

3.27

1.2

1.1

umol/24h

1.6

3.4

0.54

216

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

240

984

1.28

3.24

2.5

2.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

112

407

1.45

3.23

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

2668

13071

1.08

3.22

3.6

3.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

153

1.76

3.22

1.2

1.5

mmol/l

23.7

21.9

1.39

104

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

134

1.81

3.19

1.0

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

421

1843

1.20

3.17

2.5

e9/l

0.2

0.12

350

1601

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.17

3.16

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

258

1072

1.27

3.15

2.8

2.9

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

194

1.66

3.15

1.1

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

167

1.70

3.09

1.0

u/ml

0.5

2.5

1.31

133

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

175

1.68

3.09

2.5

3.0

pmol/l

40.4

406.2

0.52

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1342

6394

1.11

3.07

1.3

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

308

1312

1.24

3.05

1.6

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

308

1312

1.24

3.05

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

308

1312

1.24

3.05

1.6

1.9

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

237

1.58

3.04

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

227

933

1.28

3.04

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

308

1313

1.24

3.03

1.6

1.9

—

(3037556) Urate [Mass/volume] in Serum or Plasma

174

690

1.33

3.02

1.4

—

(40768793) Breast Pathology biopsy report

1140

5394

1.11

2.98

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

247

1.56

2.97

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

290

1.51

2.93

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.12

2.92

1.0

—

(3016750) Collection duration of Urine

350

1519

1.21

2.91

2.1

2.2

min

518.9

496.4

4.52

256

1159

(3033705) Calcium.ionized [Moles/volume] in Venous blood

674

3094

1.15

2.88

2.6

2.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

415

1833

1.19

2.88

1.1

u/ml

2.9

2.4

0.08

133

498

(3016031) Almond IgE Ab [Units/volume] in Serum

175

1.65

2.86

1.0

u/ml

0.7

0.5

0.23

106

(3020393) Adenovirus Ag [Presence] in Stool

279

1.51

2.86

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1081

6313

0.90

2.82

1.8

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

464

2075

1.18

2.80

2.1

2.0

13.6

14.0

0.29

218

977

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

309

1974

0.82

2.79

1.2

1.3

g/l

1.4

1.5

2.16

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

121

460

1.39

2.78

2.5

2.6

mg/l

39.2

62.2

0.60

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

228

950

1.26

2.77

1.9

2.0

157.2

167.0

0.63

216

900

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

177

1.64

2.76

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

269

1.51

2.75

1.0

u/ml

0.1

1.7

1.19

199

(3014599) Egg white IgE Ab [Units/volume] in Serum

409

1815

1.19

2.72

1.0

u/ml

2.6

4.1

0.29

109

439

(3036670) Protein [Mass/volume] in Synovial fluid

177

717

1.30

2.69

1.3

1.2

g/l

38.6

40.9

1.15

395

(3013166) Neutrophils/100 leukocytes in Synovial fluid

184

751

1.29

2.65

1.3

1.4

51.8

57.2

1.09

159

644

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

272

1.49

2.62

3.3

3.1

mg/l

1.2

1.4

0.33

182

(3000060) B lymphocytes [#/volume] in Blood

189

776

1.28

2.61

2.0

2.1

e6/l

2084.2

504.1

0.58

103

417

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

247

1.51

2.60

2.3

2.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

557

2545

1.15

2.59

2.0

2.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.00

2.56

1.0

pmol/l

228.9

212.2

0.06

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

214

895

1.26

2.56

1.1

—

(4133840)

129

901

0.75

2.53

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

288

1246

1.22

2.53

1.1

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

145

578

1.32

2.50

1.1

1.2

85.4

89.1

0.42

172

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.24

2.48

1.0

u/ml

3.4

0.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

9466

51362

0.97

2.46

2.9

ug/l

0.7

0.8

28.57

6227

32712

(3024263) Appearance of Synovial fluid

301

1314

1.21

2.43

1.6

1.8

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

347

1.41

2.43

2.4

2.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

112

792

0.74

2.42

1.2

—

(3036603) Volume of Urine

399

1788

1.18

2.41

1.5

1.7

1991.1

1926.8

0.25

443

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

795

3739

1.12

2.40

3.8

3.4

u/ml

32.4

39.1

0.95

771

3592

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.04

2.40

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

101

384

1.39

2.37

2.9

3.0

ml/dl

14.8

14.7

0.02

358

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.91

2.37

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

523

2398

1.15

2.35

1.3

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1060

5072

1.10

2.33

2.9

3.4

u/ml

605.9

947.3

0.53

938

4622

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

161

1.60

2.32

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

157

1.61

2.31

1.5

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.26

2.28

1.2

e6/l

85.2

62.4

0.16

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

214

909

1.24

2.28

1.9

1.6

u/ml

63840.2

17308.5

0.51

111

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

139

560

1.31

2.27

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

158

1.60

2.26

1.5

1.4

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.79

2.25

1.1

1.2

u/l

882.0

338.5

0.61

(3006245) CD3-CD19+ cells/100 cells in Blood

247

1068

1.22

2.23

2.0

2.2

9.5

11.1

1.37

228

994

(3014148) Varicella zoster virus Ab [Titer] in Serum

832

3942

1.11

2.23

1.1

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

314

1.41

2.20

1.2

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

142

577

1.30

2.19

1.1

1.2

73.7

76.8

0.26

165

(3052592) Norovirus Ag [Presence] in Stool

121

481

1.32

2.18

1.2

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

152

1.59

2.15

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

416

1891

1.16

2.14

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

105

410

1.35

2.14

1.1

pmol/l

1.3

7.7

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

140

1.62

2.13

1.2

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

259

1132

1.21

2.12

6.2

11.2

—

(40768441) Liver Pathology biopsy report

421

1919

1.16

2.10

1.4

—

(3006462) Nitrate [Presence] in Urine

292

1294

1.19

2.07

3.1

3.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

372

1.36

2.06

1.1

1.3

—

20.8

—

(3004775) Volume in Urine collected for unspecified duration

452

2075

1.15

2.05

2.2

2.3

702.3

672.9

0.70

320

1436

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

297

1.40

2.03

2.1

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

518

2402

1.14

2.03

1.3

1.4

e6/l

156792.2

95346.3

0.93

369

1614

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

194

828

1.23

2.02

2.2

1.9

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

333

1.38

2.02

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

236

1.45

2.02

1.4

1.3

mg/24h

276.1

405.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

298

1.40

2.00

1.0

u/ml

0.1

0.5

0.85

160

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

352

0.66

1.99

8.8

8.3

umol/l

0.3

0.24

315

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

281

1246

1.19

1.99

1.1

—

(4211845)

317

1424

1.17

1.94

3.0

2.9

—

(44786800) Granulocytes/100 leukocytes in Body fluid

291

1.39

1.94

1.2

1.4

26.5

24.4

0.19

226

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

240

1053

1.20

1.92

2.0

2.1

28.2

29.7

0.98

224

1000

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

344

1557

1.16

1.92

1.2

—

(3013466) aPTT in Blood by Coagulation assay

157

1.54

1.92

1.1

36.2

37.7

0.79

130

(3050794) Legionella sp Ab [Presence] in Serum

217

1.46

1.91

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.94

1.89

1.1

g/l

0.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

324

1.37

1.89

2.7

2.3

u/field

0.6

0.5

0.26

324

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

366

1.34

1.85

1.1

u/ml

0.0

0.2

0.96

234

(3009015) Lactate [Moles/volume] in Synovial fluid

241

1.42

1.84

1.2

1.3

mmol/l

5.9

6.7

0.51

124

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.80

1.84

1.0

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.91

1.81

1.0

u/ml

0.3

0.7

0.72

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

304

1.37

1.81

1.0

u/ml

0.3

3.9

1.03

159

(3022229) Phosphate [Moles/volume] in Urine

175

0.54

1.81

1.2

2.0

mmol/l

27.6

20.4

0.36

147

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

101

404

1.32

1.80

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

108

437

1.30

1.78

1.1

1.4

titre

137.0

144.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1821

9017

1.06

1.78

3.1

3.6

u/ml

972.6

1500.2

0.51

1546

7779

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

102

1.65

1.77

1.6

u/l

0.0

0.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

310

1403

1.16

1.76

7.9

5.6

u/ml

296.6

4311.7

0.93

255

(3016228) CD19 cells/100 cells in Blood

242

1074

1.19

1.75

2.2

2.0

9.0

8.2

0.47

233

1057

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.03

1.74

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

1153

5623

1.08

1.74

3.7

3.0

mmol/l

1.6

0.50

1135

5515

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

338

1.34

1.74

2.7

2.6

pmol/l

88.8

70.3

0.25

296

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

231

1.41

1.73

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

248

1106

1.18

1.70

2.6

2.7

au/ml

171.9

132.6

0.45

143

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

145

1.52

1.70

1.6

1.7

ug/g

188.6

173.7

0.22

127

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

272

1.37

1.69

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

4.39

1.69

1.4

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

4.39

1.69

1.4

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

4.39

1.69

1.4

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

137

1.54

1.68

1.1

u/l

55.8

50.1

0.22

106

(4212803)

206

1.43

1.68

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

327

1.34

1.67

1.3

titre

144.3

117.7

—

(3042733) HLA Ab [Presence] in Serum

166

1061

0.82

1.66

4.7

5.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

206

906

1.20

1.66

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1008

4904

1.08

1.64

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

274

1237

1.17

1.63

1.4

1.5

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

156

1.48

1.59

1.4

1.3

pmol/l

23.8

15.2

0.63

134

(3003740) Influenza virus B Ag [Presence] in Specimen

1007

4906

1.08

1.59

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.11

1.57

1.2

1.1

nmol/24h

73.4

98.0

0.97

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

273

1237

1.16

1.57

1.4

1.5

—

(3024316) Viscosity of Plasma

127

1.53

1.56

1.4

1.9

mpas

1.8

1.6

0.32

(3000034) Microalbumin [Mass/volume] in Urine

496

2340

1.12

1.55

3.0

mg/l

36.2

60.7

1.93

368

1676

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

102

1.60

1.55

1.3

u/field

1.2

1.0

0.26

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.61

1.54

1.0

1.1

u/field

2.1

0.9

0.54

(3012898) Urea [Moles/volume] in Urine

269

1.35

1.51

1.9

1.4

mmol/l

187.1

165.9

0.68

241

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

189

834

1.19

1.50

3.0

3.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

235

1058

1.17

1.48

2.2

2.0

—

(3017704) Immunofixation for Urine

288

1317

1.15

1.48

1.3

1.6

—

(3024471) HLA-A [Type]

165

1040

0.83

1.47

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.18

1.46

1.0

1.1

mmol/24h

153.2

139.7

0.40

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

137

590

1.22

1.42

1.1

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

124

529

1.23

1.40

5.0

6.1

67.9

71.5

0.74

425

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

393

1843

1.12

1.40

1.7

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.70

1.40

1.0

u/ml

0.1

0.05

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

295

1359

1.14

1.39

2.0

1.8

—

(3003694) ABO and Rh group [Type] in Blood

15888

84936

0.98

1.39

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

118

1.52

1.39

1.3

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

412

1.27

1.39

5.3

5.1

ug/min

43.5

45.4

0.10

328

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

375

1.28

1.38

1.6

1.4

nmol/l

218847.0

240135.0

0.04

314

(3015076) Soybean IgE Ab [Units/volume] in Serum

354

1652

1.13

1.37

1.0

u/ml

0.6

0.8

0.15

222

(3024932) HLA-DR beta [Type]

163

1019

0.84

1.35

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

599

2880

1.10

1.34

1.3

1.4

mmol/l

12.8

11.6

1.83

174

599

(3047189) Immunofixation for 24 hour Urine

243

1108

1.15

1.34

1.7

1.9

—

(3029612) Listeria sp Ab [Titer] in Serum

1.75

1.34

1.5

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

154

1.44

1.33

1.5

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

181

1.40

1.32

1.1

—

(44806420)

149

653

1.20

1.32

2.2

2.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

147

644

1.20

1.31

1.2

titre

1460.0

283.6

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

146

1.44

1.30

1.3

u/l

1926.7

925.5

0.30

133

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

263

1210

1.14

1.29

3.2

mg/l

8.3

7.9

0.38

201

981

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.72

1.27

5.8

5.3

mmol/l

0.2

0.09

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

147

1.43

1.27

1.1

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

147

1.43

1.27

1.0

1.3

—

438.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

260

1.32

1.25

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.59

1.25

1.0

1.1

nmol/l

215.1

272.5

1.04

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.59

1.25

1.1

1.2

ng/l

1856.7

4804.8

1.15

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

383

1809

1.12

1.24

1.4

u/l

12.5

12.9

0.49

368

1752

(3042111) Morphology [Interpretation] in Bone marrow Narrative

835

4088

1.08

1.24

1.5

1.7

—

(3034426) Prothrombin time (PT)

212

964

1.16

1.23

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

210

1274

0.87

1.22

1.2

1.3

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

1.22

0.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.07

1.21

1.0

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.72

1.21

1.1

g/l

0.0

0.1

—

(3046861) Legionella sp Ag [Presence] in Urine

131

1.45

1.21

1.2

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

198

1.36

1.20

1.1

u/ml

27.6

25.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

198

1.36

1.20

1.1

u/ml

15.7

31.6

1.51

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

115

497

1.22

1.20

1.1

1.2

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.63

1.19

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

854

4194

1.07

1.18

1.3

1.4

mmol/l

7.3

7.0

1.64

592

3003

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

154

1.40

1.17

1.2

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

141

1.42

1.16

1.3

1.8

umol/l

0.8

0.7

0.63

106

(3018738) Hemoglobin F/Hemoglobin.total in Blood

190

0.66

1.15

2.2

2.9

33.1

11.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

629

3062

1.08

1.12

1.9

ug/l

25.0

23.6

0.18

616

3003

(3022493) Free Hemoglobin [Mass/volume] in Plasma

252

1171

1.13

1.11

4.0

5.7

mg/l

916.6

3101.3

1.30

171

831

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

257

1.29

1.09

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

121

1.44

1.09

1.2

1.3

u/ml

12.4

23.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

266

1244

1.13

1.07

2.8

3.4

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.02

1.06

1.1

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

212

1269

0.88

1.05

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

134

597

1.18

1.05

1.1

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

185

1.34

1.05

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

158

1.37

1.04

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

406

1948

1.10

1.03

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.66

1.03

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

190

872

1.15

1.03

2.4

1.9

e6/l

3053.0

3401.1

0.04

126

601

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

283

1.27

1.02

1.0

u/ml

0.6

0.5

0.06

158

(40762887) Creatinine [Moles/volume] in Blood

1.68

1.02

1.1

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

401

0.79

1.02

2.4

1.3

mmol/l

7.2

7.1

0.13

134

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.72

1.02

1.1

2.1

2.9

0.72

(3032743) Legionella sp IgG Ab [Presence] in Serum

177

1.34

1.01

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

1073

5342

1.06

1.01

3.8

3.1

mmol/l

7.6

7.5

0.09

1056

5252

(40768806) Pleura Pathology biopsy report

522

2536

1.08

1.00

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

109

479

1.20

1.00

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

551

0.82

1.00

5.1

5.7

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.89

0.99

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

256

1202

1.12

0.98

2.1

2.3

ug/l

22.5

250.2

1.80

238

1152

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

107

0.59

0.98

1.0

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

2.05

0.98

1.4

2.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

151

1.36

0.98

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

165

1.34

0.96

1.6

1.8

1.7

0.5

1.34

127

(4035726)

4467

22920

1.03

0.96

1.4

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

188

1.32

0.96

1.0

1.1

u/ml

10.0

8.4

0.17

130

(3019174) dRVVT (LA screen)

258

1.27

0.95

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

191

883

1.14

0.95

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

409

1975

1.09

0.93

1.8

mg/l

3.8

3.9

0.18

378

1892

(3027874) Urate [Moles/volume] in Urine

1.48

0.90

1.0

1.1

mmol/l

1.9

9.0

0.49

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

104

1.42

0.90

1.4

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

214

1.28

0.88

1.1

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

342

1.22

0.88

1.1

1.0

—

(3034614) HLA Ag [Interpretation]

1.55

0.88

1.5

1.1

—

(3033799) Differential panel - Peritoneal fluid

164

756

1.14

0.87

2.2

1.9

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

190

0.72

0.86

1.0

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

262

1.25

0.86

1.5

2.4

—

(3035933) Granulocytes/100 leukocytes in Blood

167

772

1.14

0.86

2.5

1.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

368

1.20

0.84

1.3

1.4

9.3

12.5

0.64

182

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.83

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.83

0.0

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

156

720

1.14

0.83

1.2

—

(3012441) Differential panel - Pleural fluid

516

2532

1.07

0.82

1.5

—

(3041184) Isoniazid [Presence] in Urine

1.82

0.82

3.2

2.7

—

(40759632) Porphyrins [Mass/mass] in Stool

1.75

0.81

1.1

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

166

771

1.13

0.81

2.4

1.7

e6/l

10383.7

14010.3

0.30

409

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

222

1.26

0.80

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

229

1336

0.90

0.80

27.4

27.6

ug/l

118.3

115.9

0.18

187

1124

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.39

0.80

1.0

umol/l

18.2

13.6

—

(3009871) Measles virus Ab [Titer] in Serum

169

1002

0.89

0.79

1.7

1.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

104

468

1.17

0.78

3.0

5.3

u/l

42.0

53.6

0.95

185

(3021162) Amylase [Enzymatic activity/volume] in Specimen

400

1.18

0.78

2.9

2.8

u/l

1767.7

1588.8

0.08

360

(3044007) Cell count panel - Peritoneal fluid

152

705

1.14

0.77

2.4

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

249

1442

0.91

0.76

1.2

1.3

—

(3007147) Virus identified in Stool by Electron microscopy

2.19

0.76

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

124

568

1.15

0.75

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

197

0.75

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

158

736

1.13

0.75

1.5

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.47

0.75

1.1

1.0

u/ml

0.1

0.2

0.50

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

595

0.86

0.75

1.4

25.4

21.5

0.60

488

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

320

1.20

0.75

1.1

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

124

569

1.15

0.74

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

124

570

1.15

0.73

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

593

0.86

0.73

6.7

8.6

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.57

0.72

2.1

2.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

221

1.24

0.72

1.3

ml/s/173m2

1.3

1.5

0.25

133

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

322

1.19

0.71

3.0

2.9

—

(3001729) Color of Synovial fluid

198

1.25

0.70

1.6

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

366

1.18

0.70

1.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.62

0.70

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

232

1.23

0.69

1.0

u/ml

6.4

4.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

1.88

0.67

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.43

0.67

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

606

3370

0.95

0.66

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

113

677

0.88

0.66

7.0

8.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

120

0.70

0.65

1.2

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

188

895

1.11

0.65

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.58

0.65

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

156

736

1.12

0.64

1.8

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.64

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

196

937

1.10

0.63

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

328

1856

0.93

0.62

1.4

nmol/l

29.9

32.3

0.80

296

1733

(40758292) HTLV I+II Ab panel - Serum

505

0.86

0.62

1.3

1.4

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.52

0.61

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

448

0.86

0.61

6.5

7.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

127

595

1.12

0.60

2.5

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.55

0.59

6.0

4.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

331

1626

1.07

0.58

5.8

6.8

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

100

1.32

0.57

1.0

1.1

—

(36303858) Crystals [Presence] in Urine

1.60

0.56

1.3

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

13318

70758

0.99

0.56

4.1

21.6

22.0

1.95

5645

33601

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

152

0.76

0.56

3.3

3.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

425

1.14

0.55

1.2

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

116

683

0.89

0.55

1.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

313

0.84

0.54

1.4

72.6

71.1

0.11

256

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

330

0.85

0.54

1.3

1.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

108

638

0.89

0.54

2.8

2.6

ng/l

112.4

105.3

0.19

355

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

444

2210

1.06

0.53

3.9

3.7

u/ml

45.9

52.2

0.23

439

2179

(3044009) aPTT.lupus sensitive (LA screen)

274

1.17

0.53

1.2

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.33

0.53

1.0

u/ml

0.1

0.03

(3026692) Albumin [Mass/volume] in Peritoneal fluid

133

631

1.11

0.53

1.5

1.3

g/l

12.3

13.9

1.00

483

(3022670) pH of Venous cord blood

1.46

0.52

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

110

517

1.12

0.52

1.2

mg/l

29.7

41.7

0.14

368

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

1.32

0.52

1.0

1.1

g/l

0.2

0.28

(3013293) Extractable nuclear Ab [Presence] in Serum

389

1.14

0.50

1.6

—

(3017400) Magnesium [Moles/volume] in Urine

1.42

0.50

1.0

1.1

mmol/l

2.8

3.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

237

1.18

0.49

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

213

1209

0.93

0.49

1.2

—

(3013762) Body weight Measured

108

1.27

0.48

1.2

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

335

1662

1.06

0.47

1.4

mmol/l

5.8

5.5

3.47

312

1583

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

113

1.26

0.47

1.0

u/ml

0.1

0.2

0.51

(3032868) Hemoglobin electrophoresis panel in Blood

285

0.85

0.47

1.4

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.33

0.47

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.44

0.46

1.0

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

244

0.84

0.45

3.5

4.2

mg/l

2.4

0.05

208

(3002331) Protein [Mass/volume] in Peritoneal fluid

116

553

1.10

0.45

1.6

1.3

g/l

23.5

36.7

0.70

444

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.50

0.45

1.0

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

146

0.79

0.44

1.6

1.3

mg/l

1.7

0.06

121

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.36

0.44

3.0

4.8

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.64

0.44

1.0

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.29

0.44

1.0

u/ml

0.0

0.2

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.43

0.0

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.43

0.0

5.3

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.43

0.0

1.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

226

1.16

0.43

1.2

1.1

g/l

17.8

17.3

0.16

210

(3023383) Lactate [Moles/volume] in Pleural fluid

134

770

0.92

0.43

1.3

mmol/l

3.8

3.4

0.70

119

710

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.42

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.40

0.41

1.0

1.1

69.1

66.5

0.20

(3007919) Fasciola sp Ab [Titer] in Serum

1.40

0.41

1.0

1.1

—

(3016135) IgD [Mass/volume] in Serum

1.32

0.41

2.5

1.8

mg/l

77.4

113.9

0.31

(3026726) Creatinine [Moles/volume] in Specimen

236

0.85

0.41

2.1

2.6

umol/l

585.4

361.5

0.23

227

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

208

1.16

0.40

1.1

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.41

0.39

1.3

1.0

—

27.7

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

189

1.17

0.39

3.8

4.8

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

126

0.79

0.39

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

301

1503

1.05

0.38

1.3

1.2

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.28

0.37

1.5

1.7

ug/l

150.0

117.9

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

205

1.16

0.37

1.0

1.1

iu/ml

12.3

20.7

0.42

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.73

0.37

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

346

1736

1.05

0.36

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

1.44

0.36

1.0

1.4

nmol/l

327.2

287.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

248

1378

0.95

0.35

35.8

36.3

ug/l

7.2

7.3

0.60

225

1250

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

311

1.12

0.34

2.0

1.7

mg/l

1.8

1.7

0.28

260

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.66

0.34

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.74

0.34

6.0

8.8

—

(3035880) pH of Pleural fluid

243

1349

0.95

0.33

1.2

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.42

0.33

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

328

1805

0.96

0.32

1.2

1.3

u/l

16.6

13.8

0.91

307

1664

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

198

1.14

0.32

1.2

ug/l

103.9

109.1

0.07

124

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.35

0.31

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.75

0.31

8.3

6.4

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.32

0.31

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

212

1057

1.06

0.31

2.1

2.0

mg/l

8.4

9.5

1.83

169

845

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

120

1.18

0.31

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

116

0.82

0.31

6.9

14.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

125

1.18

0.30

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

661

3582

0.97

0.30

2.4

2.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

187

1041

0.95

0.30

2.5

3.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

137

675

1.07

0.29

1.2

1.3

ug/l

406.0

256.0

0.33

365

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

111

1.19

0.29

11.1

8.7

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.24

0.28

1.9

1.3

—

(3035060) Mercury [Moles/volume] in Blood

1.28

0.26

1.8

1.5

nmol/l

16.3

11.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

458

2335

1.03

0.26

1.3

mmol/l

6.4

6.2

0.62

419

2172

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

360

1964

0.96

0.26

1.2

—

(3018133) Calcium [Moles/volume] in Urine

461

0.92

0.26

1.5

2.0

mmol/l

2.5

2.7

0.35

412

(3004446) Plasmodium sp identified in Blood by Light microscopy

318

1.09

0.25

2.6

2.7

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

103

1.18

0.25

1.0

u/ml

0.1

—

(37019676) Renin [Units/volume] in Plasma --supine

1.29

0.24

1.0

1.1

mu/l

18.3

67.6

—

(3013862) HLA-DP [Type]

107

0.84

0.24

1.0

—

(46236302) HLA-C [Type] by High resolution typing

107

0.84

0.24

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.39

0.24

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.39

0.24

1.0

1.6

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.20

0.24

1.1

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

399

0.92

0.24

2.1

2.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.32

0.23

2.2

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

229

1156

1.04

0.23

1.1

—

(3003577) Lead [Moles/volume] in Blood

229

1.10

0.23

1.4

1.5

umol/l

0.2

0.44

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

6226

32539

1.01

0.23

1.5

1.4

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.5

—

0.8

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

10.8

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

255

1.09

0.22

1.1

u/l

23.8

19.8

0.78

165

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

153.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.26

0.21

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

403

1.07

0.21

1.5

1.6

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.32

0.21

1.2

1.1

—

(3032641) Amino acids panel - Urine

1.26

0.21

1.0

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

897

4635

1.02

0.21

1.3

ug/l

3.3

3.9

1.29

819

4206

(40763590) HLA-DQ beta [Type]

105

0.85

0.20

1.0

—

(40760409) HLA-A [Type] by High resolution

105

0.85

0.20

1.0

—

(40760410) HLA-B [Type] by High resolution

105

0.85

0.20

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

155

0.88

0.20

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.21

0.20

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

440

1.06

0.20

1.2

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

430

2205

1.03

0.20

1.6

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

171

0.89

0.19

1.1

—

(40765096) Chromosome analysis panel by Banding

134

740

0.95

0.19

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

104

518

1.06

0.19

1.8

2.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

148

0.89

0.18

1.1

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

152

1.11

0.17

1.1

1.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

223

1.09

0.17

2.3

48.8

61.7

1.39

137

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.71

0.17

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

166

840

1.04

0.17

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

108

0.88

0.16

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.18

0.16

1.0

1.1

titre

1154.4

2249.0

—

(3048879) Bone marrow aspiration report

147

744

1.04

0.16

1.5

1.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

354

1908

0.98

0.15

1.8

2.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

498

0.95

0.15

2.0

1.7

ug/l

1.7

4.0

1.39

314

(3026470) Cobalt [Mass/volume] in Blood

290

1487

1.03

0.15

1.9

2.0

ug/l

3.4

3.8

0.33

248

1321

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

206

0.92

0.15

3.0

2.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

147

745

1.04

0.15

1.4

3.2

2.6

0.35

123

625

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

112

0.89

0.13

1.9

2.7

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

360

1.05

0.13

1.2

mmol/l

1.0

1.4

0.35

225

(3006598) pH of Arterial cord blood

1.17

0.13

1.0

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

117

0.90

0.13

2.0

2.9

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

193

0.93

0.12

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

397

1.05

0.12

1.1

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

115

1.10

0.12

1.3

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.88

0.11

3.8

3.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

139

709

1.03

0.11

1.9

2.0

u/l

23.5

38.8

1.42

124

646

(3051101) Glucose [Moles/volume] in Cord blood

455

1.04

0.11

4.7

5.6

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

116

0.91

0.11

1.1

1.0

u/ml

0.4

0.2

0.29

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

433

2243

1.02

0.11

1.3

u/l

610.4

454.3

0.65

409

2130

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

394

1.04

0.10

2.6

3.0

—

(40768446) Kidney Pathology biopsy report

233

1200

1.02

0.10

1.6

1.7

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

110

0.91

0.10

1.1

1.0

u/ml

0.2

0.4

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.10

0.10

1.0

3.0

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

124

672

0.97

0.10

1.4

25.9

20.2

1.34

110

603

(3000285) Sodium [Moles/volume] in Blood

318

1.04

0.09

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

544

2830

1.01

0.09

1.3

—

(40758358) Immune stain study

109

0.92

0.09

1.0

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.91

0.08

1.1

1.0

u/ml

0.5

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

1280

6785

0.99

0.08

4.8

3.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

634

3303

1.01

0.08

1.4

1.5

g/l

33.7

33.0

0.78

569

2980

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.05

0.08

2.4

2.5

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.85

0.08

1.0

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.14

0.08

1.0

1.1

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

1.11

0.08

2.4

2.9

umol/l

31.5

39.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.11

0.08

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.11

0.08

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.11

0.08

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.11

0.08

1.0

—

(3009883) Potato IgE Ab [Units/volume] in Serum

1.11

0.08

1.0

u/ml

0.4

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.11

0.08

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.11

0.08

2.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

312

0.96

0.08

1.4

1.6

ug/l

120.7

112.0

0.24

257

(3044416) Complement C4 [Mass/volume] in Pleural fluid

119

0.93

0.07

1.1

1.2

g/l

0.1

0.34

(3028308) Erythrocytes [#/volume] in Pleural fluid

507

2697

0.99

0.07

1.5

e6/l

77581.8

51476.2

0.59

306

1612

(3034092) Cytoplasmic Ig cells/100 cells in Blood

403

1.03

0.07

12.2

6.3

—

(3014891) Appearance of Pleural fluid

338

0.97

0.07

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

199

0.95

0.07

2.5

2.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

316

0.97

0.06

1.3

1.2

u/l

45.6

298.6

1.00

220

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

128

688

0.98

0.06

1.4

1.3

37.9

38.3

0.04

469

(3012989) Citrate [Moles/time] in 24 hour Urine

0.89

0.06

2.0

1.4

mmol/24h

1.6

2.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

559

2968

0.99

0.06

1.5

e6/l

5667.9

2568.3

0.89

409

2157

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

159

852

0.98

0.06

1.9

1.7

au/ml

81.5

130.4

0.90

100

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

150

0.95

0.06

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

119

1.06

0.06

1.0

1.2

—

(40762814) Titanium [Mass/volume] in Blood

426

0.98

0.05

2.3

ug/l

3.9

3.8

0.04

144

(3025577) Chromium [Mass/volume] in Blood

279

1453

1.01

0.05

2.0

2.1

ug/l

2.4

2.3

0.09

229

1224

(3020356) Listeria sp identified in Specimen by Organism specific culture

213

0.96

0.05

1.2

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

177

1.04

0.04

2.6

2.3

17.3

16.0

0.09

(40768795) Lymph node Pathology biopsy report

495

2623

0.99

0.04

1.2

—

(3025315) Body weight

255

0.97

0.04

4.9

4.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

164

852

1.01

0.04

1.4

62.3

62.9

0.08

137

697

(3027570) Oxalate [Moles/time] in 24 hour Urine

175

0.96

0.04

1.5

1.3

umol/24h

306.8

313.5

0.08

175

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

282

1.03

0.04

1.1

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

162

1.04

0.04

1.0

—

(3045788) Cell count panel - Pleural fluid

434

2299

0.99

0.03

1.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.07

0.03

1.1

1.0

—

(3020650) Glucose [Presence] in Urine

146

759

1.01

0.03

1.5

1.4

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.10

0.03

1.0

1.3

u/field

0.8

0.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

194

1.03

0.03

4.9

5.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

153

0.96

0.03

1.0

u/ml

0.3

12.8

0.51

(3007700) Barley IgE Ab [Units/volume] in Serum

137

0.96

0.03

1.0

u/ml

1.2

11.1

0.45

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

142

1.04

0.03

1.0

1.1

—

(21494434) Karyotype in Bone marrow

416

2180

1.00

0.02

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

209

1106

0.99

0.01

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

448

1.01

0.01

1.2

mmol/l

1.5

1.7

0.53

277

(3018291) Platelet Ab [Presence] in Serum

1.07

0.01

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

262

0.98

0.01

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

181

1.02

0.00

2.1

2.4

—

(3049242) von Willebrand panel - Platelet poor plasma

0.99

0.00

1.2

1.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.97

0.00

1.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.95

0.00

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

163

1.00

0.00

1.2

1.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

173

1.00

0.00

1.0

1.1

u/ml

1.7

1.2

0.18

124

(3013336) Amino acids [Identifier] in Serum or Plasma

1.03

0.00

1.8

2.6

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.01

0.00

1.2

mg/l

20.3

31.7

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

143

0.99

0.00

10.3

10.5

e6/l

114.2

235.7

0.84

106

(3018001) Oat IgE Ab [Units/volume] in Serum

201

1.00

0.00

1.1

1.0

u/ml

0.4

1.2

0.49

(4281824)

521

2743

1.00

0.00

1.1

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

160

0.99

0.00

1.6

1.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.03

0.00

1.1

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

169

1.00

0.00

4.4

5.3

—

(4038314)

276

1.01

0.00

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.96

0.00

1.7

1.1

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3049233) Organic acids panel - Urine

0.97

0.00

1.2

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.96

0.00

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: SSRI – Selective serotonin reuptake inhibitors

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Selective serotonin reuptake inhibitors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Selective serotonin reuptake inhibitors (SSRI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints